{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:48:33Z","timestamp":1794649713152,"version":"4.9.1"},"reference-count":546,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and\/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.<\/jats:p>","DOI":"10.1038\/s41413-024-00398-6","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T01:47:06Z","timestamp":1740448026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects"],"prefix":"10.1038","volume":"13","author":[{"given":"Qin","family":"Ru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3404-0807","authenticated-orcid":false,"given":"Yusheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9041-4471","authenticated-orcid":false,"given":"Yuxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-0003","authenticated-orcid":false,"given":"Fudi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"398_CR1","doi-asserted-by":"publisher","first-page":"a006023","DOI":"10.1101\/cshperspect.a006023","volume":"7","author":"IY Kuo","year":"2015","unstructured":"Kuo, I. Y. & Ehrlich, B. E. Signaling in muscle contraction. Cold Spring Harb. Perspect. Biol. 7, a006023 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"398_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","volume":"41","author":"MCK Severinsen","year":"2020","unstructured":"Severinsen, M. C. K. & Pedersen, B. K. Muscle-organ crosstalk the emerging roles of myokines. Endocr. Rev. 41, 594\u2013609 (2020).","journal-title":"Endocr. Rev."},{"key":"398_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.acc.2019.07.010","volume":"94","author":"M Gomarasca","year":"2020","unstructured":"Gomarasca, M., Banfi, G. & Lombardi, G. Myokines: the endocrine coupling of skeletal muscle and bone. Adv. Clin. Chem. 94, 155\u2013218 (2020).","journal-title":"Adv. Clin. Chem."},{"key":"398_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","volume":"4","author":"S Liu","year":"2019","unstructured":"Liu, S. et al. Burden of cardiovascular diseases in China, 1990\u20132016 findings From the 2016 Global Burden of Disease Study. JAMA Cardiol. 4, 342\u2013352 (2019).","journal-title":"JAMA Cardiol."},{"key":"398_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 394, 1145\u20131158 (2019).","journal-title":"Lancet"},{"key":"398_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., Ardehali, H., Min, J. & Wang, F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 20, 7\u201323 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"398_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf4345","volume":"9","author":"Y Che","year":"2023","unstructured":"Che, Y. et al. Iron deficiency-induced ferritinophagy impairs skeletal muscle regeneration through RNF20-mediated H2Bub1 modification. Sci. Adv. 9, eadf4345 (2023).","journal-title":"Sci. Adv."},{"key":"398_CR8","doi-asserted-by":"crossref","unstructured":"Shoemaker M. E. et al. Influences of vitamin D and iron status on skeletal muscle health: a narrative review. Nutrients 14, 2717 (2022).","DOI":"10.3390\/nu14132717"},{"key":"398_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"398_CR10","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.scib.2021.02.026","volume":"66","author":"S Xu","year":"2021","unstructured":"Xu, S., Min, J. & Wang, F. Ferroptosis: an emerging player in immune cells. Sci. Bull. 66, 2257\u20132260 (2021).","journal-title":"Sci. Bull."},{"key":"398_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18, 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"398_CR12","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","volume":"30","author":"D Tang","year":"2020","unstructured":"Tang, D. & Kroemer, G. Ferroptosis. Curr. Biol. 30, R1292\u2013R1297 (2020).","journal-title":"Curr. Biol."},{"key":"398_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"398_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.29117","volume":"66","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology 66, 449\u2013465 (2017).","journal-title":"Hepatology"},{"key":"398_CR15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"398_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng, J. & Conrad, M. The metabolic underpinnings of ferroptosis. Cell Metab. 32, 920\u2013937 (2020).","journal-title":"Cell Metab."},{"key":"398_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan, H. et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem. Biophys. Res. Commun. 478, 1338\u20131343 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"398_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"398_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"24","author":"HL Zhang","year":"2022","unstructured":"Zhang, H. L. et al. PKCbetaII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat. Cell Biol. 24, 88\u201398 (2022).","journal-title":"Nat. Cell Biol."},{"key":"398_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378e366 (2022).","journal-title":"Cancer Cell"},{"key":"398_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41401-023-01156-w","volume":"45","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. Acta Pharm. Sin. 45, 150\u2013165 (2024).","journal-title":"Acta Pharm. Sin."},{"key":"398_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41413-023-00247-y","volume":"11","author":"Q Ru","year":"2023","unstructured":"Ru, Q. et al. Fighting age-related orthopedic diseases: focusing on ferroptosis. Bone Res 11, 12 (2023).","journal-title":"Bone Res"},{"key":"398_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jcsm.12700","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding, H. et al. Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis. J. Cachexia, Sarcopenia Muscle 12, 746\u2013768 (2021).","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"398_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11684-023-0992-z","volume":"17","author":"X Wang","year":"2023","unstructured":"Wang, X., Zhou, Y., Min, J. & Wang, F. Zooming in and out of ferroptosis in human disease. Front Med. 17, 173\u2013206 (2023).","journal-title":"Front Med."},{"key":"398_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-024-07623-6","volume":"631","author":"HKC Co","year":"2024","unstructured":"Co, H. K. C., Wu, C. C., Lee, Y. C. & Chen, S. H. Emergence of large-scale cell death through ferroptotic trigger waves. Nature 631, 654\u2013662 (2024).","journal-title":"Nature"},{"key":"398_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000530046","volume":"9","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. A panoramic view of ferroptosis in cardiovascular disease. Kidney Dis. 9, 173\u2013186 (2023).","journal-title":"Kidney Dis."},{"key":"398_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru, Q. et al. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct. Target Ther. 9, 271 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"398_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy, B., Conrad, M. & Muckenthaler, M. Mechanisms controlling cellular and systemic iron homeostasis. Nat. Rev. Mol. Cell Biol. 25, 133\u2013155 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"398_CR29","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.scib.2021.02.010","volume":"66","author":"Q Mu","year":"2021","unstructured":"Mu, Q. et al. The role of iron homeostasis in remodeling immune function and regulating inflammatory disease. Sci. Bull. 66, 1806\u20131816 (2021).","journal-title":"Sci. Bull."},{"key":"398_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jcp.21.4.495","volume":"21","author":"JD Torrance","year":"1968","unstructured":"Torrance, J. D. et al. Storage iron in \u201cmuscle\u201d. J. Clin. Pathol. 21, 495\u2013500 (1968).","journal-title":"J. Clin. Pathol."},{"key":"398_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/bj0830291","volume":"83","author":"L Golberg","year":"1962","unstructured":"Golberg, L., Martin, L. E. & Batchelor, A. Biochemical changes in the tissues of animals injected with iron. 3. Lipid peroxidation. Biochem J. 83, 291\u2013298 (1962).","journal-title":"Biochem J."},{"key":"398_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1172\/JCI108489","volume":"58","author":"CA Finch","year":"1976","unstructured":"Finch, C. A. et al. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J. Clin. Investig. 58, 447\u2013453 (1976).","journal-title":"J. Clin. Investig."},{"key":"398_CR33","first-page":"4766","volume":"48","author":"S Rajagopalan","year":"1988","unstructured":"Rajagopalan, S., Politi, P. M., Sinha, B. K. & Myers, C. E. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 48, 4766\u20134769 (1988).","journal-title":"Cancer Res."},{"key":"398_CR34","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai, E. et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat. Cell Biol. 26, 1447\u20131457 (2024).","journal-title":"Nat. Cell Biol."},{"key":"398_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao, M. et al. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 59, 298\u2013308 (2015).","journal-title":"Mol. Cell"},{"key":"398_CR36","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X. et al. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl Acad. Sci. USA 116, 2672\u20132680 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"398_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","volume":"127","author":"X Fang","year":"2020","unstructured":"Fang, X. et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ. Res. 127, 486\u2013501 (2020).","journal-title":"Circ. Res."},{"key":"398_CR38","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/jcsm.12953","volume":"13","author":"S He","year":"2022","unstructured":"He, S. et al. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke. J. Cachexia Sarcopenia Muscle 13, 1717\u20131730 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"398_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41392-024-01962-6","volume":"9","author":"X Bi","year":"2024","unstructured":"Bi, X. et al. Characterization of ferroptosis-triggered pyroptotic signaling in heart failure. Signal Transduct. Target Ther. 9, 257 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"398_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. Ferroptosis: past, present and future. Cell Death Dis. 11, 88 (2020).","journal-title":"Cell Death Dis."},{"key":"398_CR41","doi-asserted-by":"publisher","unstructured":"Wang X. et al. Adipocyte-derived ferroptotic signaling mitigates obesity. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2024.11.010 (2024).","DOI":"10.1016\/j.cmet.2024.11.010"},{"key":"398_CR42","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","volume":"119","author":"L Da Dalt","year":"2023","unstructured":"Da Dalt, L., Cabodevilla, A. G., Goldberg, I. J. & Norata, G. D. Cardiac lipid metabolism, mitochondrial function, and heart failure. Cardiovasc. Res. 119, 1905\u20131914 (2023).","journal-title":"Cardiovasc. Res."},{"key":"398_CR43","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIRCRESAHA.122.321833","volume":"132","author":"Z Nichtova","year":"2023","unstructured":"Nichtova, Z. et al. Enhanced mitochondria-SR tethering triggers adaptive cardiac muscle remodeling. Circ. Res. 132, e171\u2013e187 (2023).","journal-title":"Circ. Res."},{"key":"398_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrd.2016.248","volume":"16","author":"BJ Crielaard","year":"2017","unstructured":"Crielaard, B. J., Lammers, T. & Rivella, S. Targeting iron metabolism in drug discovery and delivery. Nat. Rev. Drug Discov. 16, 400\u2013423 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"398_CR45","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1360\/SSV-2023-0192","volume":"53","author":"F Wang","year":"2023","unstructured":"Wang, F. Ferrology: a charming boundless iron-centric science. Sci. Sin. Vitae 53, 1331\u20131344 (2023).","journal-title":"Sci. Sin. Vitae"},{"key":"398_CR46","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2003-09-3139","volume":"103","author":"H Chen","year":"2004","unstructured":"Chen, H. et al. Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice. Blood 103, 3933\u20133939 (2004).","journal-title":"Blood"},{"key":"398_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022853","volume":"11","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Myocardial iron deficiency and mitochondrial dysfunction in advanced heart failure in humans. J. Am. Heart Assoc. 11, e022853 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"398_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky, V. et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur. J. Heart Fail 19, 522\u2013530 (2017).","journal-title":"Eur. J. Heart Fail"},{"key":"398_CR49","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00037.2020","volume":"102","author":"TCSt Keller","year":"2022","unstructured":"Keller, T. C. St et al. The role of globins in cardiovascular physiology. Physiol. Rev. 102, 859\u2013892 (2022).","journal-title":"Physiol. Rev."},{"key":"398_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jinorgbio.2016.12.010","volume":"168","author":"C Matias","year":"2017","unstructured":"Matias, C. et al. Citrate and albumin facilitate transferrin iron loading in the presence of phosphate. J. Inorg. Biochem. 168, 107\u2013113 (2017).","journal-title":"J. Inorg. Biochem."},{"key":"398_CR51","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"CH Park","year":"2001","unstructured":"Park, C. H., Valore, E. V., Waring, A. J. & Ganz, T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806\u20137810 (2001).","journal-title":"J. Biol. Chem."},{"key":"398_CR52","doi-asserted-by":"publisher","first-page":"1903366","DOI":"10.1002\/advs.201903366","volume":"7","author":"J Li","year":"2020","unstructured":"Li, J. et al. Transferrin receptor 1 regulates thermogenic capacity and cell fate in brown\/beige adipocytes. Adv. Sci. 7, 1903366 (2020).","journal-title":"Adv. Sci."},{"key":"398_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","volume":"13","author":"W Xu","year":"2015","unstructured":"Xu, W. et al. Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep. 13, 533\u2013545 (2015).","journal-title":"Cell Rep."},{"key":"398_CR54","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ebiom.2015.09.041","volume":"2","author":"T Barrientos","year":"2015","unstructured":"Barrientos, T. et al. Metabolic catastrophe in mice lacking transferrin receptor in muscle. EBioMedicine 2, 1705\u20131717 (2015).","journal-title":"EBioMedicine"},{"key":"398_CR55","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1182\/blood-2021-154296","volume":"138","author":"L QL","year":"2021","unstructured":"QL, L., Azucenas, C., Mackenzie, B. & Knutson, M. Metal-ion transporter SLC39A14 is required for cardiac iron loading in the Hjv mouse model of iron overload. Blood 138, 758 (2021).","journal-title":"Blood"},{"key":"398_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/ph11040137","volume":"11","author":"N Sukhbaatar","year":"2018","unstructured":"Sukhbaatar, N. & Weichhart, T. Iron regulation: macrophages in control. Pharmaceuticals 11, 137 (2018).","journal-title":"Pharmaceuticals"},{"key":"398_CR57","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s44318-024-00064-x","volume":"43","author":"Q Wu","year":"2024","unstructured":"Wu, Q. et al. Ferritin heavy chain supports stability and function of the regulatory T cell lineage. EMBO J. 43, 1445\u20131483 (2024).","journal-title":"EMBO J."},{"key":"398_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias, J. D. et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105\u2013109 (2014).","journal-title":"Nature"},{"key":"398_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","volume":"160","author":"N Li","year":"2020","unstructured":"Li, N. et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic. Biol. Med. 160, 303\u2013318 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR60","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","volume":"586","author":"CB Billesbolle","year":"2020","unstructured":"Billesbolle, C. B. et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature 586, 807\u2013811 (2020).","journal-title":"Nature"},{"key":"398_CR61","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090\u20132093 (2004).","journal-title":"Science"},{"key":"398_CR62","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood.2020008986","volume":"138","author":"L Jiang","year":"2021","unstructured":"Jiang, L. et al. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood 138, 689\u2013705 (2021).","journal-title":"Blood"},{"key":"398_CR63","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1073\/pnas.1422373112","volume":"112","author":"S Lakhal-Littleton","year":"2015","unstructured":"Lakhal-Littleton, S. et al. Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc. Natl. Acad. Sci. USA 112, 3164\u20133169 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"398_CR64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijcard.2015.07.089","volume":"201","author":"X Fang","year":"2015","unstructured":"Fang, X. et al. Cardiomyocyte-specific deletion of ferroportin using MCK-Cre has no apparent effect on cardiac iron homeostasis. Int. J. Cardiol. 201, 90\u201392 (2015).","journal-title":"Int. J. Cardiol."},{"key":"398_CR65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/152308603770310158","volume":"5","author":"DW Killilea","year":"2003","unstructured":"Killilea, D. W., Atamna, H., Liao, C. & Ames, B. N. Iron accumulation during cellular senescence in human fibroblasts in vitro. Antioxid. Redox Signal. 5, 507\u2013516 (2003).","journal-title":"Antioxid. Redox Signal."},{"key":"398_CR66","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward, R. J. et al. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13, 1045\u20131060 (2014).","journal-title":"Lancet Neurol."},{"key":"398_CR67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/gerona\/glac139","volume":"78","author":"FM Alves","year":"2023","unstructured":"Alves, F. M. et al. Age-Related Changes in Skeletal Muscle Iron Homeostasis. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 78, 16\u201324 (2023).","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"398_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mad.2018.07.003","volume":"175","author":"AA Wawer","year":"2018","unstructured":"Wawer, A. A., Jennings, A. & Fairweather-Tait, S. J. Iron status in the elderly: a review of recent evidence. Mech. Ageing Dev. 175, 55\u201373 (2018).","journal-title":"Mech. Ageing Dev."},{"key":"398_CR69","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3324\/haematol.2012.068825","volume":"98","author":"WP den Elzen","year":"2013","unstructured":"den Elzen, W. P. et al. Plasma hepcidin levels and anemia in old age. The Leiden 85-plus study. Haematologica 98, 448\u2013454 (2013).","journal-title":"Haematologica"},{"key":"398_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101510","volume":"72","author":"RS Zeidan","year":"2021","unstructured":"Zeidan, R. S., Han, S. M., Leeuwenburgh, C. & Xiao, R. Iron homeostasis and organismal aging. Ageing Res. Rev. 72, 101510 (2021).","journal-title":"Ageing Res. Rev."},{"key":"398_CR71","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jand.2018.09.007","volume":"119","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Association between body iron status and leukocyte telomere length, a biomarker of biological aging, in a nationally representative sample of US adults. J. Acad. Nutr. Diet. 119, 617\u2013625 (2019).","journal-title":"J. Acad. Nutr. Diet."},{"key":"398_CR72","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2014.07.061","volume":"8","author":"S Carnio","year":"2014","unstructured":"Carnio, S. et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Rep. 8, 1509\u20131521 (2014).","journal-title":"Cell Rep."},{"key":"398_CR73","doi-asserted-by":"publisher","first-page":"151","DOI":"10.7150\/ijbs.53126","volume":"17","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8). Int. J. Biol. Sci. 17, 151\u2013162 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"398_CR74","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/jcsm.12283","volume":"9","author":"M Halon-Golabek","year":"2018","unstructured":"Halon-Golabek, M. et al. hmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway. J. Cachexia, Sarcopenia Muscle 9, 557\u2013569 (2018).","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"398_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0828-282X(09)70064-9","volume":"25","author":"S Lekawanvijit","year":"2009","unstructured":"Lekawanvijit, S. & Chattipakorn, N. Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity. Can. J. Cardiol. 25, 213\u2013218 (2009).","journal-title":"Can. J. Cardiol."},{"key":"398_CR76","first-page":"489","volume":"88","author":"A Piga","year":"2003","unstructured":"Piga, A., Gaglioti, C., Fogliacco, E. & Tricta, F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica 88, 489\u2013496 (2003).","journal-title":"Haematologica"},{"key":"398_CR77","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","volume":"107","author":"DJ Pennell","year":"2006","unstructured":"Pennell, D. J. et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 107, 3738\u20133744 (2006).","journal-title":"Blood"},{"key":"398_CR78","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/ejhf.2454","volume":"24","author":"F Papalia","year":"2022","unstructured":"Papalia, F. et al. Cardiac energetics in patients with chronic heart failure and iron deficiency: an in-vivo (31) P magnetic resonance spectroscopy study. Eur. J. Heart Fail 24, 716\u2013723 (2022).","journal-title":"Eur. J. Heart Fail"},{"key":"398_CR79","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/jcsm.13277","volume":"14","author":"JSJ Vinke","year":"2023","unstructured":"Vinke, J. S. J. et al. Iron deficiency is related to lower muscle mass in community-dwelling individuals and impairs myoblast proliferation. J. Cachexia Sarcopenia Muscle 14, 1865\u20131879 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"398_CR80","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1096\/fj.201901815R","volume":"34","author":"PA Leermakers","year":"2020","unstructured":"Leermakers, P. A. et al. Iron deficiency-induced loss of skeletal muscle mitochondrial proteins and respiratory capacity; the role of mitophagy and secretion of mitochondria-containing vesicles. FASEB J. 34, 6703\u20136717 (2020).","journal-title":"FASEB J."},{"key":"398_CR81","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/nu13041056","volume":"13","author":"E Rineau","year":"2021","unstructured":"Rineau, E. et al. Iron deficiency without anemia decreases physical endurance and mitochondrial complex I activity of oxidative skeletal muscle in the mouse. Nutrients 13, 1056 (2021).","journal-title":"Nutrients"},{"key":"398_CR82","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip, I. T. et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am. Heart J. 165, 575\u2013582 e573 (2013).","journal-title":"Am. Heart J."},{"key":"398_CR83","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/ejhf.1781","volume":"22","author":"VG Hirsch","year":"2020","unstructured":"Hirsch, V. G. et al. Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction. Eur. J. Heart Fail 22, 2038\u20132046 (2020).","journal-title":"Eur. J. Heart Fail"},{"key":"398_CR84","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014254","volume":"9","author":"J Nunez","year":"2020","unstructured":"Nunez, J. et al. Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the myocardial-IRON Trial. J. Am. Heart Assoc. 9, e014254 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"398_CR85","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ejhf.1154","volume":"20","author":"MF Hoes","year":"2018","unstructured":"Hoes, M. F. et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur. J. Heart Fail 20, 910\u2013919 (2018).","journal-title":"Eur. J. Heart Fail"},{"key":"398_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.909670","volume":"10","author":"B Feng","year":"2022","unstructured":"Feng, B. et al. Mitochondrial-targeted ratiometric fluorescent probe to monitor ClO(-) induced by ferroptosis in living cells. Front. Chem. 10, 909670 (2022).","journal-title":"Front. Chem."},{"key":"398_CR87","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","volume":"146","author":"KF Docherty","year":"2022","unstructured":"Docherty, K. F. et al. Iron deficiency in heart failure and effect of dapagliflozin: findings From DAPA-HF. Circulation 146, 980\u2013994 (2022).","journal-title":"Circulation"},{"key":"398_CR88","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","volume":"20","author":"M Packer","year":"2023","unstructured":"Packer, M. SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism. Nat. Rev. Cardiol. 20, 443\u2013462 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"398_CR89","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood.2019002907","volume":"136","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood 136, 726\u2013739 (2020).","journal-title":"Blood"},{"key":"398_CR90","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. USA 113, E4966\u2013E4975 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"398_CR91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"398_CR92","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou, W. et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12, 1425\u20131428 (2016).","journal-title":"Autophagy"},{"key":"398_CR93","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao, M. et al. Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021\u20131032 (2016).","journal-title":"Cell Res."},{"key":"398_CR94","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.devcel.2019.10.007","volume":"51","author":"CW Brown","year":"2019","unstructured":"Brown, C. W. et al. Prominin2 drives ferroptosis resistance by stimulating iron export. Dev. Cell 51, 575\u2013586.e574 (2019).","journal-title":"Dev. Cell"},{"key":"398_CR95","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez, S. W. et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551, 639\u2013643 (2017).","journal-title":"Nature"},{"key":"398_CR96","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbrc.2016.08.034","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan, H. et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem. Biophys. Res. Commun. 478, 838\u2013844 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"398_CR97","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2018.06.018","volume":"432","author":"EH Kim","year":"2018","unstructured":"Kim, E. H. et al. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer. Cancer Lett. 432, 180\u2013190 (2018).","journal-title":"Cancer Lett."},{"key":"398_CR98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/bs.ctdb.2024.01.018","volume":"158","author":"C Guilhot","year":"2024","unstructured":"Guilhot, C., Catenacci, M., Lofaro, S. & Rudnicki, M. A. The satellite cell in skeletal muscle: a story of heterogeneity. Curr. Top. Dev. Biol. 158, 15\u201351 (2024).","journal-title":"Curr. Top. Dev. Biol."},{"key":"398_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2014.00001","volume":"2","author":"N Motohashi","year":"2014","unstructured":"Motohashi, N. & Asakura, A. Muscle satellite cell heterogeneity and self-renewal. Front. Cell Dev. Biol. 2, 1 (2014).","journal-title":"Front. Cell Dev. Biol."},{"key":"398_CR100","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1161\/ATVBAHA.123.319518","volume":"43","author":"L Tran","year":"2023","unstructured":"Tran, L. et al. Transcriptomic profiling identifies ferroptosis-related gene signatures in ischemic muscle satellite cells affected by peripheral artery disease-brief report. Arterioscler. Thromb. Vasc. Biol. 43, 2023\u20132029 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"398_CR101","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1096\/fj.201802724RR","volume":"33","author":"Y Ikeda","year":"2019","unstructured":"Ikeda, Y. et al. Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress. FASEB J. 33, 9551\u20139564 (2019).","journal-title":"FASEB J."},{"key":"398_CR102","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1021\/acs.jproteome.4c00123","volume":"23","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Taurine alleviates ferroptosis-induced metabolic impairments in C2C12 myoblasts by stabilizing the labile iron pool and improving redox homeostasis. J. Proteome Res. 23, 3444\u20133459 (2024).","journal-title":"J. Proteome Res."},{"key":"398_CR103","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41419-023-06192-2","volume":"14","author":"N Motohashi","year":"2023","unstructured":"Motohashi, N., Minegishi, K. & Aoki, Y. Inherited myogenic abilities in muscle precursor cells defined by the mitochondrial complex I-encoding protein. Cell Death Dis. 14, 689 (2023).","journal-title":"Cell Death Dis."},{"key":"398_CR104","doi-asserted-by":"crossref","unstructured":"Ortuste Quiroga H. P. et al. Fine-tuning of piezo1 expression and activity ensures efficient myoblast fusion during skeletal myogenesis. Cells 11, (2022).","DOI":"10.3390\/cells11030393"},{"key":"398_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04436-w","volume":"9","author":"M Tsuchiya","year":"2018","unstructured":"Tsuchiya, M. et al. Cell surface flip-flop of phosphatidylserine is critical for PIEZO1-mediated myotube formation. Nat. Commun. 9, 2049 (2018).","journal-title":"Nat. Commun."},{"key":"398_CR106","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jcp.1041310306","volume":"131","author":"LM Sorokin","year":"1987","unstructured":"Sorokin, L. M., Morgan, E. H. & Yeoh, G. C. Transferrin receptor numbers and transferrin and iron uptake in cultured chick muscle cells at different stages of development. J. Cell Physiol. 131, 342\u2013353 (1987).","journal-title":"J. Cell Physiol."},{"key":"398_CR107","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1194\/jlr.M013292","volume":"52","author":"DL Golej","year":"2011","unstructured":"Golej, D. L. et al. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E(2) release from human arterial smooth muscle cells. J. Lipid Res 52, 782\u2013793 (2011).","journal-title":"J. Lipid Res"},{"key":"398_CR108","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong, L. et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem. Biol. 26, 420\u2013432 e429 (2019).","journal-title":"Cell Chem. Biol."},{"key":"398_CR109","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon, S. J. et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol. 10, 1604\u20131609 (2015).","journal-title":"ACS Chem. Biol."},{"key":"398_CR110","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/ars.2023.0237","volume":"39","author":"J Cui","year":"2023","unstructured":"Cui, J. et al. LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity. Antioxid. Redox Signal. 39, 491\u2013511 (2023).","journal-title":"Antioxid. Redox Signal."},{"key":"398_CR111","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","volume":"171","author":"SE Wenzel","year":"2017","unstructured":"Wenzel, S. E. et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell 171, 628\u2013641 e626 (2017).","journal-title":"Cell"},{"key":"398_CR112","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu, B. et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat. Cell Biol. 21, 579\u2013591 (2019).","journal-title":"Nat. Cell Biol."},{"key":"398_CR113","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat. Chem. Biol. 16, 302\u2013309 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"398_CR114","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang, W. H. et al. The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 28, 2501\u20132508.e2504 (2019).","journal-title":"Cell Rep."},{"key":"398_CR115","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra1810762","volume":"380","author":"Y Epstein","year":"2019","unstructured":"Epstein, Y. & Yanovich, R. Heatstroke. N. Engl. J. Med. 380, 2449\u20132459 (2019).","journal-title":"N. Engl. J. Med."},{"key":"398_CR116","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1055\/a-1400-9754","volume":"42","author":"O Laitano","year":"2021","unstructured":"Laitano, O., Oki, K. & Leon, L. R. The role of skeletal muscles in exertional heat stroke pathophysiology. Int. J. Sports Med. 42, 673\u2013681 (2021).","journal-title":"Int. J. Sports Med."},{"key":"398_CR117","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41419-022-05462-9","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Activation of ALOX12 by a multi-organelle-orienting photosensitizer drives ACSL4-independent cell ferroptosis. Cell Death Dis. 13, 1040 (2022).","journal-title":"Cell Death Dis."},{"key":"398_CR118","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai, W. et al. Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation 147, 1444\u20131460 (2023).","journal-title":"Circulation"},{"key":"398_CR119","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41392-022-01090-z","volume":"7","author":"XH Ma","year":"2022","unstructured":"Ma, X. H. et al. ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduct. Target Ther. 7, 288 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"398_CR120","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5732956","volume":"2020","author":"R D\u2019Oria","year":"2020","unstructured":"D\u2019Oria, R. et al. The role of oxidative stress in cardiac disease: from physiological response to injury factor. Oxid. Med. Cell Longev. 2020, 5732956 (2020).","journal-title":"Oxid. Med. Cell Longev."},{"key":"398_CR121","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cardfail.2012.04.003","volume":"18","author":"S Radovanovic","year":"2012","unstructured":"Radovanovic, S. et al. Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure. J. Card. Fail 18, 493\u2013501 (2012).","journal-title":"J. Card. Fail"},{"key":"398_CR122","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","volume":"129","author":"W Li","year":"2019","unstructured":"Li, W. et al. Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation. J. Clin. Investig. 129, 2293\u20132304 (2019).","journal-title":"J. Clin. Investig."},{"key":"398_CR123","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways. Acta Pharm. Sin. B 12, 708\u2013722 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"398_CR124","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao, J. Y. & Dixon, S. J. Mechanisms of ferroptosis. Cell. Mol. life Sci.: CMLS 73, 2195\u20132209 (2016).","journal-title":"Cell. Mol. life Sci.: CMLS"},{"key":"398_CR125","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini, F. & Maiorino, M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic. Biol. Med. 152, 175\u2013185 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR126","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","volume":"274","author":"H Sato","year":"1999","unstructured":"Sato, H., Tamba, M., Ishii, T. & Bannai, S. Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455\u201311458 (1999).","journal-title":"J. Biol. Chem."},{"key":"398_CR127","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","volume":"39","author":"MR Liu","year":"2021","unstructured":"Liu, M. R., Zhu, W. T. & Pei, D. S. System Xc(-): a key regulatory target of ferroptosis in cancer. Investig. N. drugs 39, 1123\u20131131 (2021).","journal-title":"Investig. N. drugs"},{"key":"398_CR128","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41422-022-00642-w","volume":"32","author":"R Yan","year":"2022","unstructured":"Yan, R. et al. The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis. Cell Res. 32, 687\u2013690 (2022).","journal-title":"Cell Res."},{"key":"398_CR129","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599\u2013620 (2021).","journal-title":"Protein Cell"},{"key":"398_CR130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/abbi.1999.1527","volume":"373","author":"Z Chen","year":"2000","unstructured":"Chen, Z., Putt, D. A. & Lash, L. H. Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport. Arch. Biochem. Biophys. 373, 193\u2013202 (2000).","journal-title":"Arch. Biochem. Biophys."},{"key":"398_CR131","doi-asserted-by":"crossref","unstructured":"Sreekumar P. G., Ferrington D. A., Kannan R. Glutathione metabolism and the novel role of mitochondrial GSH in retinal degeneration. Antioxidants 10, (2021).","DOI":"10.3390\/antiox10050661"},{"key":"398_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66837-6","volume":"10","author":"G Pan","year":"2020","unstructured":"Pan, G. et al. SLC25A11 serves as a novel prognostic biomarker in liver cancer. Sci. Rep. 10, 9871 (2020).","journal-title":"Sci. Rep."},{"key":"398_CR133","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.redox.2017.08.022","volume":"14","author":"A Baulies","year":"2018","unstructured":"Baulies, A. et al. The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol. 14, 164\u2013177 (2018).","journal-title":"Redox Biol."},{"key":"398_CR134","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.febslet.2015.01.027","volume":"589","author":"LM Booty","year":"2015","unstructured":"Booty, L. M. et al. The mitochondrial dicarboxylate and 2-oxoglutarate carriers do not transport glutathione. FEBS Lett. 589, 621\u2013628 (2015).","journal-title":"FEBS Lett."},{"key":"398_CR135","doi-asserted-by":"publisher","first-page":"127511","DOI":"10.1016\/j.ijbiomac.2023.127511","volume":"253","author":"E Shin","year":"2023","unstructured":"Shin, E. et al. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma. Int. J. Biol. Macromol. 253, 127511 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"398_CR136","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/ars.2022.0203","volume":"39","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. SLC25A22 as a key mitochondrial transporter against ferroptosis by producing glutathione and monounsaturated fatty acids. Antioxid. Redox Signal. 39, 166\u2013185 (2023).","journal-title":"Antioxid. Redox Signal."},{"key":"398_CR137","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-021-04025-w","volume":"599","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells. Nature 599, 136\u2013140 (2021).","journal-title":"Nature"},{"key":"398_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30126-9","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Combinatorial GxGxE CRISPR screen identifies SLC25A39 in mitochondrial glutathione transport linking iron homeostasis to OXPHOS. Nat. Commun. 13, 2483 (2022).","journal-title":"Nat. Commun."},{"key":"398_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina, G. C. & Dixon, S. J. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics 19, e1800311 (2019).","journal-title":"Proteomics"},{"key":"398_CR140","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107\u2013125 (2021).","journal-title":"Cell Res."},{"key":"398_CR141","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.chembiol.2015.11.016","volume":"23","author":"K Shimada","year":"2016","unstructured":"Shimada, K., Hayano, M., Pagano, N. C. & Stockwell, B. R. Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity. Cell Chem. Biol. 23, 225\u2013235 (2016).","journal-title":"Cell Chem. Biol."},{"key":"398_CR142","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/antiox10060890","volume":"10","author":"A Vermot","year":"2021","unstructured":"Vermot, A., Petit-Hartlein, I., Smith, S. M. E. & Fieschi, F. NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants 10, 890 (2021).","journal-title":"Antioxidants"},{"key":"398_CR143","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"398_CR144","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 14, 519 (2023).","journal-title":"Cell Death Dis."},{"key":"398_CR145","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao, M. et al. Role of mitochondria in ferroptosis. Mol. Cell 73, 354\u2013363 e353 (2019).","journal-title":"Mol. Cell"},{"key":"398_CR146","doi-asserted-by":"publisher","first-page":"28104","DOI":"10.1021\/acsnano.4c07558","volume":"18","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Bioorthogonal regulated metabolic balance for promotion of ferroptosis and mild photothermal therapy. ACS Nano 18, 28104\u201328114 (2024).","journal-title":"ACS Nano"},{"key":"398_CR147","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan, B. et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol. Cell 81, 355\u2013369 e310 (2021).","journal-title":"Mol. Cell"},{"key":"398_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","volume":"30","author":"HJ Forman","year":"2009","unstructured":"Forman, H. J., Zhang, H. & Rinna, A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Asp. Med. 30, 1\u201312 (2009).","journal-title":"Mol. Asp. Med."},{"key":"398_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102021","volume":"45","author":"S Jang","year":"2021","unstructured":"Jang, S. et al. Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes. Redox Biol. 45, 102021 (2021).","journal-title":"Redox Biol."},{"key":"398_CR150","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019).","journal-title":"Nature"},{"key":"398_CR151","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft, V. A. N. et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent. Sci. 6, 41\u201353 (2020).","journal-title":"ACS Cent. Sci."},{"key":"398_CR152","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351\u20131360 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"398_CR153","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/ars.2021.0136","volume":"37","author":"J Vasquez-Vivar","year":"2022","unstructured":"Vasquez-Vivar, J., Shi, Z. & Tan, S. Tetrahydrobiopterin in cell function and death mechanisms. Antioxid. redox Signal. 37, 171\u2013183 (2022).","journal-title":"Antioxid. redox Signal."},{"key":"398_CR154","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64806","volume":"10","author":"L Zeitler","year":"2021","unstructured":"Zeitler, L. et al. Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism. eLife 10, e64806 (2021).","journal-title":"eLife"},{"key":"398_CR155","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41417-020-0170-2","volume":"27","author":"C Dai","year":"2020","unstructured":"Dai, C. et al. Transcription factors in ferroptotic cell death. Cancer Gene Ther. 27, 645\u2013656 (2020).","journal-title":"Cancer Gene Ther."},{"key":"398_CR156","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","volume":"133","author":"R Kang","year":"2019","unstructured":"Kang, R., Kroemer, G. & Tang, D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic. Biol. Med. 133, 162\u2013168 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR157","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli, C., Chio, I. I. C. & Tuveson, D. A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal. 29, 1727\u20131745 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"398_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101791","volume":"38","author":"P La Rosa","year":"2021","unstructured":"La Rosa, P. et al. The Nrf2 induction prevents ferroptosis in Friedreich\u2019s Ataxia. Redox Biol. 38, 101791 (2021).","journal-title":"Redox Biol."},{"key":"398_CR159","doi-asserted-by":"publisher","first-page":"155135","DOI":"10.1016\/j.phymed.2023.155135","volume":"122","author":"R Yang","year":"2024","unstructured":"Yang, R. et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis. Phytomedicine 122, 155135 (2024).","journal-title":"Phytomedicine"},{"key":"398_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15074","volume":"8","author":"CS Shin","year":"2017","unstructured":"Shin, C. S. et al. The glutamate\/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat. Commun. 8, 15074 (2017).","journal-title":"Nat. Commun."},{"key":"398_CR161","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173\u2013184 (2016).","journal-title":"Hepatology"},{"key":"398_CR162","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","volume":"416","author":"LC Chang","year":"2018","unstructured":"Chang, L. C. et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 416, 124\u2013137 (2018).","journal-title":"Cancer Lett."},{"key":"398_CR163","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A Anandhan","year":"2023","unstructured":"Anandhan, A. et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci. Adv. 9, eade9585 (2023).","journal-title":"Sci. Adv."},{"key":"398_CR164","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 27, 662\u2013675 (2020).","journal-title":"Cell Death Differ."},{"key":"398_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113052","volume":"179","author":"S Zhao","year":"2021","unstructured":"Zhao, S. et al. Recent advances of electrochemical sensors for detecting and monitoring ROS\/RNS. Biosens. Bioelectron. 179, 113052 (2021).","journal-title":"Biosens. Bioelectron."},{"key":"398_CR166","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 572, 402\u2013406 (2019).","journal-title":"Nature"},{"key":"398_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115902","volume":"437","author":"X Sun","year":"2022","unstructured":"Sun, X. et al. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression. Toxicol. Appl Pharm. 437, 115902 (2022).","journal-title":"Toxicol. Appl Pharm."},{"key":"398_CR168","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1021\/acsnano.1c10921","volume":"16","author":"L Hou","year":"2022","unstructured":"Hou, L. et al. Targeted Intervention of NF2-YAP signaling axis in CD24-overexpressing cells contributes to encouraging therapeutic effects in TNBC. ACS Nano 16, 5807\u20135819 (2022).","journal-title":"ACS Nano"},{"key":"398_CR169","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.7150\/thno.55482","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics 11, 5650\u20135674 (2021).","journal-title":"Theranostics"},{"key":"398_CR170","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114351","volume":"13","author":"R Gao","year":"2021","unstructured":"Gao, R. et al. YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol. Med. 13, e14351 (2021).","journal-title":"EMBO Mol. Med."},{"key":"398_CR171","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401251R","volume":"38","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. A novel mechanism of ferroptosis inhibition-enhanced atherosclerotic plaque stability: YAP1 suppresses vascular smooth muscle cell ferroptosis through GLS1. FASEB J. 38, e23850 (2024).","journal-title":"FASEB J."},{"key":"398_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101032","volume":"297","author":"K Igarashi","year":"2021","unstructured":"Igarashi, K., Nishizawa, H., Saiki, Y. & Matsumoto, M. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis. J. Biol. Chem. 297, 101032 (2021).","journal-title":"J. Biol. Chem."},{"key":"398_CR173","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1074\/jbc.RA119.009548","volume":"295","author":"H Nishizawa","year":"2020","unstructured":"Nishizawa, H. et al. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J. Biol. Chem. 295, 69\u201382 (2020).","journal-title":"J. Biol. Chem."},{"key":"398_CR174","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13235","volume":"19","author":"WD Bao","year":"2020","unstructured":"Bao, W. D. et al. Targeting miR-124\/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model. Aging Cell 19, e13235 (2020).","journal-title":"Aging Cell"},{"key":"398_CR175","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/cells8101135","volume":"8","author":"S Jiang","year":"2019","unstructured":"Jiang, S. et al. MiR-20b down-regulates intestinal ferroportin expression in vitro and in vivo. Cells 8, 1135 (2019).","journal-title":"Cells"},{"key":"398_CR176","doi-asserted-by":"publisher","first-page":"e1003408","DOI":"10.1371\/journal.pgen.1003408","volume":"9","author":"C Sangokoya","year":"2013","unstructured":"Sangokoya, C., Doss, J. F. & Chi, J. T. Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin. PLoS Genet 9, e1003408 (2013).","journal-title":"PLoS Genet"},{"key":"398_CR177","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00109-015-1362-3","volume":"94","author":"KR Babu","year":"2016","unstructured":"Babu, K. R. & Muckenthaler, M. U. miR-20a regulates expression of the iron exporter ferroportin in lung cancer. J. Mol. Med. 94, 347\u2013359 (2016).","journal-title":"J. Mol. Med."},{"key":"398_CR178","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-010-0849-4","volume":"126","author":"SI Shpyleva","year":"2011","unstructured":"Shpyleva, S. I. et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res. Treat. 126, 63\u201371 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"398_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174403","volume":"909","author":"K Fan","year":"2021","unstructured":"Fan, K. et al. The Egr-1\/miR-15a-5p\/GPX4 axis regulates ferroptosis in acute myocardial infarction. Eur. J. Pharm. 909, 174403 (2021).","journal-title":"Eur. J. Pharm."},{"key":"398_CR180","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2021.05.100","volume":"566","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. miR-190a-5p regulates cardiomyocytes response to ferroptosis via directly targeting GLS2. Biochem. Biophys. Res. Commun. 566, 9\u201315 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"398_CR181","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","volume":"29","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol. Ther. 29, 263\u2013274 (2021).","journal-title":"Mol. Ther."},{"key":"398_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118305","volume":"260","author":"J Lu","year":"2020","unstructured":"Lu, J., Xu, F. & Lu, H. LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53. Life Sci. 260, 118305 (2020).","journal-title":"Life Sci."},{"key":"398_CR183","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","volume":"26","author":"M Wang","year":"2019","unstructured":"Wang, M. et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 26, 2329\u20132343 (2019).","journal-title":"Cell Death Differ."},{"key":"398_CR184","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","volume":"12","author":"W Luo","year":"2021","unstructured":"Luo, W. et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis. 12, 1043 (2021).","journal-title":"Cell Death Dis."},{"key":"398_CR185","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1111\/jcmm.16890","volume":"25","author":"T Ni","year":"2021","unstructured":"Ni, T., Huang, X., Pan, S. & Lu, Z. Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J. Cell Mol. Med. 25, 9995\u201310007 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"398_CR186","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cellsig.2017.07.002","volume":"38","author":"S Guo","year":"2017","unstructured":"Guo, S. et al. The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesis. Cell. Signal. 38, 106\u2013115 (2017).","journal-title":"Cell. Signal."},{"key":"398_CR187","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exphem.2017.01.002","volume":"49","author":"K Inokura","year":"2017","unstructured":"Inokura, K. et al. Impact of TET2 deficiency on iron metabolism in erythroblasts. Exp. Hematol. 49, 56\u201367.e55 (2017).","journal-title":"Exp. Hematol."},{"key":"398_CR188","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1182\/blood-2016-08-736587","volume":"129","author":"H Yan","year":"2017","unstructured":"Yan, H. et al. Distinct roles for TET family proteins in regulating human erythropoiesis. Blood 129, 2002\u20132012 (2017).","journal-title":"Blood"},{"key":"398_CR189","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12870","volume":"48","author":"S Udali","year":"2018","unstructured":"Udali, S. et al. Hepcidin and DNA promoter methylation in hepatocellular carcinoma. Eur. J. Clin. Investig. 48, e12870 (2018).","journal-title":"Eur. J. Clin. Investig."},{"key":"398_CR190","doi-asserted-by":"publisher","first-page":"e0197863","DOI":"10.1371\/journal.pone.0197863","volume":"13","author":"PA Sharp","year":"2018","unstructured":"Sharp, P. A. et al. DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression. PloS One 13, e0197863 (2018).","journal-title":"PloS One"},{"key":"398_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103067","volume":"70","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21\/Nrf2 activation in a HuR-dependent m6A manner. Redox Biol. 70, 103067 (2024).","journal-title":"Redox Biol."},{"key":"398_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167307","volume":"1870","author":"H Zeng","year":"2024","unstructured":"Zeng, H. et al. FTO alleviated ferroptosis in septic cardiomyopathy via mediating the m6A modification of BACH1. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 167307 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"398_CR193","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10863-024-10006-1","volume":"56","author":"Z Tang","year":"2024","unstructured":"Tang, Z., Huang, X., Mei, H. & Zheng, Z. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner. J. Bioenerg. Biomembr. 56, 149\u2013157 (2024).","journal-title":"J. Bioenerg. Biomembr."},{"key":"398_CR194","doi-asserted-by":"crossref","unstructured":"Liao M. et al. METTL3-mediated m6A modification of NORAD inhibits the ferroptosis of vascular smooth muscle cells to attenuate the aortic dissection progression in an YTHDF2-dependent manner. Mol. Cell Biochem. 479, 3471\u20133487 (2024).","DOI":"10.1007\/s11010-024-04930-4"},{"key":"398_CR195","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwad227","volume":"10","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. YTHDF2-mediated regulations bifurcate BHPF-induced programmed cell deaths. Natl Sci. Rev. 10, nwad227 (2023).","journal-title":"Natl Sci. Rev."},{"key":"398_CR196","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2011.10.038","volume":"200","author":"PF Silva","year":"2012","unstructured":"Silva, P. F. et al. Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated by sodium butyrate. Neuroscience 200, 42\u201349 (2012).","journal-title":"Neuroscience"},{"key":"398_CR197","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bcp.2010.04.008","volume":"80","author":"W Wang","year":"2010","unstructured":"Wang, W., Di, X., Torti, S. V. & Torti, F. M. Ferritin H induction by histone deacetylase inhibitors. Biochem. Pharmacol. 80, 316\u2013324 (2010).","journal-title":"Biochem. Pharmacol."},{"key":"398_CR198","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1172\/JCI88574","volume":"127","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2. J. Clin. Invest 127, 1505\u20131516 (2017).","journal-title":"J. Clin. Invest"},{"key":"398_CR199","doi-asserted-by":"publisher","first-page":"e46631","DOI":"10.1371\/journal.pone.0046631","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu, H. et al. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. PloS one 7, e46631 (2012).","journal-title":"PloS one"},{"key":"398_CR200","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","volume":"2","author":"RH Wang","year":"2005","unstructured":"Wang, R. H. et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2, 399\u2013409 (2005).","journal-title":"Cell Metab."},{"key":"398_CR201","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1089\/ars.2017.7161","volume":"28","author":"X Yin","year":"2018","unstructured":"Yin, X. et al. HDAC1 governs iron homeostasis independent of histone deacetylation in iron-overload murine models. Antioxid. redox Signal. 28, 1224\u20131237 (2018).","journal-title":"Antioxid. redox Signal."},{"key":"398_CR202","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.freeradbiomed.2024.04.220","volume":"219","author":"Y He","year":"2024","unstructured":"He, Y. et al. SP2509 functions as a novel ferroptosis inhibitor by reducing intracellular iron level in vascular smooth muscle cells. Free Radic. Biol. Med. 219, 49\u201363 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR203","doi-asserted-by":"publisher","first-page":"106122","DOI":"10.1016\/j.phrs.2022.106122","volume":"177","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection. Pharm. Res. 177, 106122 (2022).","journal-title":"Pharm. Res."},{"key":"398_CR204","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41556-023-01133-9","volume":"25","author":"K Wu","year":"2023","unstructured":"Wu, K. et al. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nat. Cell Biol. 25, 714\u2013725 (2023).","journal-title":"Nat. Cell Biol."},{"key":"398_CR205","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2023.06.004","volume":"205","author":"HH Liao","year":"2023","unstructured":"Liao, H. H. et al. Activation of AMPKalpha2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis. Free Radic. Biol. Med. 205, 275\u2013290 (2023).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR206","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/pharmaceutics16030393","volume":"16","author":"M Gunther","year":"2024","unstructured":"Gunther, M. et al. AMPK activation by Cimicifuga racemosa extract Ze 450 is associated with metabolic effects and cellular resilience against age-related pathologies in different tissue cell types. Pharmaceutics 16, 393 (2024).","journal-title":"Pharmaceutics"},{"key":"398_CR207","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41418-022-01110-z","volume":"30","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction. Cell Death Differ. 30, 825\u2013838 (2023).","journal-title":"Cell Death Differ."},{"key":"398_CR208","volume":"2020","author":"X Li","year":"2020","unstructured":"Li, X. et al. Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via Akt\/GSK-3beta\/Nrf2 pathway. Oxid. Med Cell Longev. 2020, 6286984 (2020).","journal-title":"Oxid. Med Cell Longev."},{"key":"398_CR209","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41418-022-00957-6","volume":"29","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Ubiquitin ligase E3 HUWE1\/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death Differ. 29, 1705\u20131718 (2022).","journal-title":"Cell Death Differ."},{"key":"398_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121608","volume":"321","author":"X Sun","year":"2023","unstructured":"Sun, X. et al. TRIM21 ubiquitylates GPX4 and promotes ferroptosis to aggravate ischemia\/reperfusion-induced acute kidney injury. Life Sci. 321, 121608 (2023).","journal-title":"Life Sci."},{"key":"398_CR211","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/15384101.2019.1597506","volume":"18","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Koppula, P. & Gan, B. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1. Cell Cycle 18, 773\u2013783 (2019).","journal-title":"Cell Cycle"},{"key":"398_CR212","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","volume":"16","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy 16, 1482\u20131505 (2020).","journal-title":"Autophagy"},{"key":"398_CR213","doi-asserted-by":"publisher","first-page":"145968","DOI":"10.1016\/j.gene.2021.145968","volume":"808","author":"T Li","year":"2022","unstructured":"Li, T. et al. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene 808, 145968 (2022).","journal-title":"Gene"},{"key":"398_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110655","volume":"107","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity. Cell. Signal. 107, 110655 (2023).","journal-title":"Cell. Signal."},{"key":"398_CR215","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.7150\/ijms.50804","volume":"18","author":"YT Bai","year":"2021","unstructured":"Bai, Y. T. et al. Hypoxia protects H9c2 cells against Ferroptosis through SENP1-mediated protein DeSUMOylation. Int J. Med Sci. 18, 1618\u20131627 (2021).","journal-title":"Int J. Med Sci."},{"key":"398_CR216","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2023.04.034","volume":"366","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Acetylation, ferroptosis, and their potential relationships: Implications in myocardial ischemia-reperfusion injury. Am. J. Med Sci. 366, 176\u2013184 (2023).","journal-title":"Am. J. Med Sci."},{"key":"398_CR217","doi-asserted-by":"crossref","unstructured":"Su H. et al. SIRT3 deficiency enhances ferroptosis and promotes cardiac fibrosis via p53 acetylation. Cells 12, (2023).","DOI":"10.3390\/cells12101428"},{"key":"398_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109870","volume":"78","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Yu, R., Wu, L. & Yang, G. Hydrogen sulfide guards myoblasts from ferroptosis by inhibiting ALOX12 acetylation. Cell. Signal. 78, 109870 (2021).","journal-title":"Cell. Signal."},{"key":"398_CR219","doi-asserted-by":"publisher","first-page":"105145","DOI":"10.1016\/j.nbd.2020.105145","volume":"147","author":"O Rroji","year":"2021","unstructured":"Rroji, O., Kumar, A., Karuppagounder, S. S. & Ratan, R. R. Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases. Neurobiol. Dis. 147, 105145 (2021).","journal-title":"Neurobiol. Dis."},{"key":"398_CR220","doi-asserted-by":"publisher","DOI":"10.34133\/research.0281","volume":"6","author":"H Meng","year":"2023","unstructured":"Meng, H. et al. Hepatic HDAC3 regulates systemic iron homeostasis and ferroptosis via the Hippo signaling pathway. Research 6, 0281 (2023).","journal-title":"Research"},{"key":"398_CR221","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian, K. & Stockwell, B. R. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat. Rev. Drug Discov. 22, 723\u2013742 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"398_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102971","volume":"69","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma. Redox Biol. 69, 102971 (2024).","journal-title":"Redox Biol."},{"key":"398_CR223","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi, E. & Brunham, L. R. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 12, 339 (2021).","journal-title":"Cell Death Dis."},{"key":"398_CR224","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169756","volume":"8","author":"T Tadokoro","year":"2023","unstructured":"Tadokoro, T. et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 8, e169756 (2023).","journal-title":"JCI Insight"},{"key":"398_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154840","volume":"122","author":"Z Pei","year":"2021","unstructured":"Pei, Z. et al. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis. Metabolism 122, 154840 (2021).","journal-title":"Metabolism"},{"key":"398_CR226","doi-asserted-by":"publisher","first-page":"9145","DOI":"10.1080\/21655979.2022.2036895","volume":"13","author":"Z Lu","year":"2022","unstructured":"Lu, Z., Liu, Z. & Fang, B. Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2\/glutathione peroxidase 4 signaling pathways. Bioengineered 13, 9145\u20139155 (2022).","journal-title":"Bioengineered"},{"key":"398_CR227","doi-asserted-by":"publisher","first-page":"960327121106453","DOI":"10.1177\/09603271211064537","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Arsenic trioxide-induced cardiotoxicity triggers ferroptosis in cardiomyoblast cells. Hum. Exp. Toxicol. 41, 9603271211064537 (2022).","journal-title":"Hum. Exp. Toxicol."},{"key":"398_CR228","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-020-02777-3","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis. 11, 574 (2020).","journal-title":"Cell Death Dis."},{"key":"398_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106086","volume":"176","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis. Pharm. Res. 176, 106086 (2022).","journal-title":"Pharm. Res."},{"key":"398_CR230","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41421-022-00390-6","volume":"8","author":"F Yu","year":"2022","unstructured":"Yu, F. et al. Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis. Cell Discov. 8, 40 (2022).","journal-title":"Cell Discov."},{"key":"398_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103158","volume":"72","author":"T Li","year":"2024","unstructured":"Li, T. et al. PM(2.5)-induced iron homeostasis imbalance triggers cardiac hypertrophy through ferroptosis in a selective autophagy crosstalk manner. Redox Biol. 72, 103158 (2024).","journal-title":"Redox Biol."},{"key":"398_CR232","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s10495-024-01963-4","volume":"29","author":"E Wang","year":"2024","unstructured":"Wang, E. et al. LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway. Apoptosis 29, 1648\u20131662 (2024).","journal-title":"Apoptosis"},{"key":"398_CR233","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","volume":"88","author":"BK Pedersen","year":"2008","unstructured":"Pedersen, B. K. & Febbraio, M. A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379\u20131406 (2008).","journal-title":"Physiol. Rev."},{"key":"398_CR234","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen, B. K. & Febbraio, M. A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457\u2013465 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"398_CR235","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cphy.c120033","volume":"3","author":"BK Pedersen","year":"2013","unstructured":"Pedersen, B. K. Muscle as a secretory organ. Compr. Physiol. 3, 1337\u20131362 (2013).","journal-title":"Compr. Physiol."},{"key":"398_CR236","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2014.12.021","volume":"21","author":"KK Baskin","year":"2015","unstructured":"Baskin, K. K., Winders, B. R. & Olson, E. N. Muscle as a \u201cmediator\u201d of systemic metabolism. Cell Metab. 21, 237\u2013248 (2015).","journal-title":"Cell Metab."},{"key":"398_CR237","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41574-022-00641-2","volume":"18","author":"LS Chow","year":"2022","unstructured":"Chow, L. S. et al. Exerkines in health, resilience and disease. Nat. Rev. Endocrinol. 18, 273\u2013289 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"398_CR238","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1111\/febs.12338","volume":"280","author":"P Munoz-Canoves","year":"2013","unstructured":"Munoz-Canoves, P., Scheele, C., Pedersen, B. K. & Serrano, A. L. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 280, 4131\u20134148 (2013).","journal-title":"FEBS J."},{"key":"398_CR239","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s42255-022-00538-4","volume":"4","author":"TM Kistner","year":"2022","unstructured":"Kistner, T. M., Pedersen, B. K. & Lieberman, D. E. Interleukin 6 as an energy allocator in muscle tissue. Nat. Metab. 4, 170\u2013179 (2022).","journal-title":"Nat. Metab."},{"key":"398_CR240","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.autrev.2017.11.010","volume":"17","author":"K Sharif","year":"2018","unstructured":"Sharif, K. et al. Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun. Rev. 17, 53\u201372 (2018).","journal-title":"Autoimmun. Rev."},{"key":"398_CR241","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41574-022-00724-0","volume":"18","author":"GA Brooks","year":"2022","unstructured":"Brooks, G. A. et al. Lactate as a major myokine and exerkine. Nat. Rev. Endocrinol. 18, 712 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"398_CR242","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1096\/fj.201700381RR","volume":"32","author":"T Hashimoto","year":"2018","unstructured":"Hashimoto, T. et al. Maintained exercise-enhanced brain executive function related to cerebral lactate metabolism in men. FASEB J. 32, 1417\u20131427 (2018).","journal-title":"FASEB J."},{"key":"398_CR243","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1096\/fj.201901433R","volume":"33","author":"C Torres-Fuentes","year":"2019","unstructured":"Torres-Fuentes, C. et al. Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling. FASEB J. 33, 13546\u201313559 (2019).","journal-title":"FASEB J."},{"key":"398_CR244","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1172\/JCI59701","volume":"122","author":"M Bordicchia","year":"2012","unstructured":"Bordicchia, M. et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Investig. 122, 1022\u20131036 (2012).","journal-title":"J. Clin. Investig."},{"key":"398_CR245","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.molcel.2023.05.008","volume":"83","author":"M A","year":"2023","unstructured":"A, M. et al. Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90alpha. Mol. Cell 83, 1903\u20131920 e1912 (2023).","journal-title":"Mol. Cell"},{"key":"398_CR246","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.173","volume":"10","author":"S Wei","year":"2020","unstructured":"Wei, S. et al. Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice. Clin. Transl. Med. 10, e173 (2020).","journal-title":"Clin. Transl. Med."},{"key":"398_CR247","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2022.05.023","volume":"187","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2\/GPX4 signal axis. Free Radic. Biol. Med. 187, 171\u2013184 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR248","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/cbin.11763","volume":"46","author":"G Cao","year":"2022","unstructured":"Cao, G. et al. FNDC5\/irisin reduces ferroptosis and improves mitochondrial dysfunction in hypoxic cardiomyocytes by Nrf2\/HO-1 axis. Cell Biol. Int. 46, 723\u2013736 (2022).","journal-title":"Cell Biol. Int."},{"key":"398_CR249","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Postconditioning with irisin attenuates lung ischemia\/reperfusion injury by suppressing ferroptosis via induction of the Nrf2\/HO-1 Signal Axis. Oxid. Med. Cell Longev. 2022, 9911167 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"398_CR250","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-024-02183-5","volume":"23","author":"YJ Tang","year":"2024","unstructured":"Tang, Y. J. et al. Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53. Cardiovasc. Diabetol. 23, 116 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"398_CR251","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2023.09.001","volume":"62","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Irisin as an agent for protecting against osteoporosis: a review of the current mechanisms and pathways. J. Adv. Res. 62, 175\u2013186 (2024).","journal-title":"J. Adv. Res."},{"key":"398_CR252","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.3390\/ijms251810116","volume":"25","author":"C Zhao","year":"2024","unstructured":"Zhao, C. et al. Irisin protects musculoskeletal homeostasis via a mitochondrial quality control mechanism. Int J. Mol. Sci. 25, 10116 (2024).","journal-title":"Int J. Mol. Sci."},{"key":"398_CR253","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13018-024-04701-3","volume":"19","author":"Q Dong","year":"2024","unstructured":"Dong, Q., Han, Z., Gao, M. & Tian, L. FNDC5\/irisin ameliorates bone loss of type 1 diabetes by suppressing endoplasmic reticulum stress\u2011mediated ferroptosis. J. Orthop. Surg. Res. 19, 205 (2024).","journal-title":"J. Orthop. Surg. Res."},{"key":"398_CR254","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14181","volume":"23","author":"L Tao","year":"2024","unstructured":"Tao, L. et al. Exerkine FNDC5\/irisin-enriched exosomes promote proliferation and inhibit ferroptosis of osteoblasts through interaction with Caveolin-1. Aging Cell 23, e14181 (2024).","journal-title":"Aging Cell"},{"key":"398_CR255","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1210\/endrev\/bnab030","volume":"43","author":"BD Rodgers","year":"2022","unstructured":"Rodgers, B. D. & Ward, C. W. Myostatin\/activin receptor ligands in muscle and the development status of attenuating drugs. Endocr. Rev. 43, 329\u2013365 (2022).","journal-title":"Endocr. Rev."},{"key":"398_CR256","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12866-022-02687-8","volume":"22","author":"C Du","year":"2022","unstructured":"Du, C. et al. Inactivation of the MSTN gene expression changes the composition and function of the gut microbiome in sheep. BMC Microbiol. 22, 273 (2022).","journal-title":"BMC Microbiol."},{"key":"398_CR257","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.116.308391","volume":"118","author":"RG Walker","year":"2016","unstructured":"Walker, R. G. et al. Biochemistry and biology of GDF11 and myostatin: similarities, differences, and questions for future investigation. Circ. Res. 118, 1125\u20131141 (2016).","journal-title":"Circ. Res."},{"key":"398_CR258","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153517","volume":"491","author":"YH Tang","year":"2023","unstructured":"Tang, Y. H. et al. Hydrogen sulfide antagonizes formaldehyde-induced ferroptosis via preventing ferritinophagy by upregulation of GDF11 in HT22 cells. Toxicology 491, 153517 (2023).","journal-title":"Toxicology"},{"key":"398_CR259","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the physiology of FGF21. Annu. Rev. Physiol. 78, 223\u2013241 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"398_CR260","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.10.003","volume":"33","author":"F Li","year":"2017","unstructured":"Li, F. et al. Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue. Cytokine Growth Factor Rev. 33, 73\u201382 (2017).","journal-title":"Cytokine Growth Factor Rev."},{"key":"398_CR261","doi-asserted-by":"publisher","first-page":"102131","DOI":"10.1016\/j.redox.2021.102131","volume":"46","author":"A Wu","year":"2021","unstructured":"Wu, A. et al. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biol. 46, 102131 (2021).","journal-title":"Redox Biol."},{"key":"398_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155278","volume":"123","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Grape seed-derived procyanidin inhibits glyphosate-induced hepatocyte ferroptosis via enhancing crosstalk between Nrf2 and FGF12. Phytomedicine 123, 155278 (2024).","journal-title":"Phytomedicine"},{"key":"398_CR263","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.4103\/1673-5374.387979","volume":"19","author":"Q Gu","year":"2024","unstructured":"Gu, Q. et al. Fibroblast growth factor 21 inhibits ferroptosis following spinal cord injury by regulating heme oxygenase-1. Neural Regen. Res. 19, 1568\u20131574 (2024).","journal-title":"Neural Regen. Res."},{"key":"398_CR264","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110753","volume":"202","author":"T Xu","year":"2023","unstructured":"Xu, T. et al. FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1\/beta-Klotho pathway. Brain Res. Bull. 202, 110753 (2023).","journal-title":"Brain Res. Bull."},{"key":"398_CR265","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12933-024-02469-8","volume":"23","author":"R Wang","year":"2024","unstructured":"Wang, R. et al. Fibroblast growth factor 21 improves diabetic cardiomyopathy by inhibiting ferroptosis via ferritin pathway. Cardiovasc Diabetol. 23, 394 (2024).","journal-title":"Cardiovasc Diabetol."},{"key":"398_CR266","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cytogfr.2019.03.003","volume":"46","author":"D Eberle","year":"2019","unstructured":"Eberle, D. et al. Elabela and Apelin actions in healthy and pathological pregnancies. Cytokine Growth Factor Rev. 46, 45\u201353 (2019).","journal-title":"Cytokine Growth Factor Rev."},{"key":"398_CR267","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/cvr\/cvad171","volume":"119","author":"FA Chapman","year":"2023","unstructured":"Chapman, F. A. et al. Targeting the apelin system for the treatment of cardiovascular diseases. Cardiovasc Res. 119, 2683\u20132696 (2023).","journal-title":"Cardiovasc Res."},{"key":"398_CR268","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pharmthera.2018.05.013","volume":"190","author":"A Mughal","year":"2018","unstructured":"Mughal, A. & O\u2019Rourke, S. T. Vascular effects of apelin: Mechanisms and therapeutic potential. Pharm. Ther. 190, 139\u2013147 (2018).","journal-title":"Pharm. Ther."},{"key":"398_CR269","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/pharmaceutics15031029","volume":"15","author":"SV Popov","year":"2023","unstructured":"Popov, S. V. et al. Apelin is a prototype of novel drugs for the treatment of acute myocardial infarction and adverse myocardial remodeling. Pharmaceutics 15, 1029 (2023).","journal-title":"Pharmaceutics"},{"key":"398_CR270","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02518-7","volume":"19","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Apelin alleviated neuroinflammation and promoted endogenous neural stem cell proliferation and differentiation after spinal cord injury in rats. J. Neuroinflamm. 19, 160 (2022).","journal-title":"J. Neuroinflamm."},{"key":"398_CR271","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00018-020-03461-7","volume":"77","author":"J Yan","year":"2020","unstructured":"Yan, J., Wang, A., Cao, J. & Chen, L. Apelin\/APJ system: an emerging therapeutic target for respiratory diseases. Cell. Mol. Life Sci.: CMLS 77, 2919\u20132930 (2020).","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"398_CR272","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fphar.2017.00221","volume":"8","author":"X Lv","year":"2017","unstructured":"Lv, X., Kong, J., Chen, W. D. & Wang, Y. D. The role of the Apelin\/APJ system in the regulation of liver disease. Front. Pharm. 8, 221 (2017).","journal-title":"Front. Pharm."},{"key":"398_CR273","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/ijo.2013.158","volume":"38","author":"A Besse-Patin","year":"2014","unstructured":"Besse-Patin, A. et al. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J. Obes. 38, 707\u2013713 (2014).","journal-title":"Int J. Obes."},{"key":"398_CR274","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","volume":"181","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling. Free Radic. Biol. Med. 181, 130\u2013142 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR275","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2023.01.008","volume":"196","author":"P Xu","year":"2023","unstructured":"Xu, P. et al. Elabela-APJ axis attenuates cerebral ischemia\/reperfusion injury by inhibiting neuronal ferroptosis. Free Radic. Biol. Med. 196, 171\u2013186 (2023).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR276","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116217","volume":"274","author":"Y Nie","year":"2024","unstructured":"Nie, Y. et al. Interference with SPARC inhibits benzophenone-3 induced ferroptosis in osteoarthritis: evidence from bioinformatics analyses and biological experimentation. Ecotoxicol. Environ. Saf. 274, 116217 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"398_CR277","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s10020-023-00729-z","volume":"29","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Beta-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK\/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury. Mol. Med. 29, 164 (2023).","journal-title":"Mol. Med."},{"key":"398_CR278","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcsm.12839","volume":"12","author":"O Gungor","year":"2021","unstructured":"Gungor, O. et al. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J. Cachexia Sarcopenia Muscle 12, 1380\u20131392 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"398_CR279","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers12010003","volume":"12","author":"AR Shakri","year":"2019","unstructured":"Shakri, A. R. et al. Upregulation of ZIP14 and altered zinc homeostasis in muscles in pancreatic cancer cachexia. Cancers 12, 3 (2019).","journal-title":"Cancers"},{"key":"398_CR280","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41418-022-00990-5","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2\/GPX4 pathway. Cell Death Differ. 29, 1982\u20131995 (2022).","journal-title":"Cell Death Differ."},{"key":"398_CR281","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nm.4462","volume":"24","author":"K Okubo","year":"2018","unstructured":"Okubo, K. et al. Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat. Med. 24, 232\u2013238 (2018).","journal-title":"Nat. Med."},{"key":"398_CR282","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/jbmr.4293","volume":"36","author":"NC Harvey","year":"2021","unstructured":"Harvey, N. C. et al. Sarcopenia definitions as predictors of fracture risk independent of FRAX((R)), Falls, and BMD in the osteoporotic fractures in men (MrOS) study: a meta-analysis. J. Bone Min. Res. 36, 1235\u20131244 (2021).","journal-title":"J. Bone Min. Res."},{"key":"398_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101200","volume":"65","author":"P Wiedmer","year":"2021","unstructured":"Wiedmer, P. et al. Sarcopenia\u2014molecular mechanisms and open questions. Ageing Res. Rev. 65, 101200 (2021).","journal-title":"Ageing Res. Rev."},{"key":"398_CR284","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. Lancet 393, 2636\u20132646 (2019).","journal-title":"Lancet"},{"key":"398_CR285","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.maturitas.2011.04.008","volume":"69","author":"ME den Ouden","year":"2011","unstructured":"den Ouden, M. E., Schuurmans, M. J., Arts, I. E. & van der Schouw, Y. T. Physical performance characteristics related to disability in older persons: a systematic review. Maturitas 69, 208\u2013219 (2011).","journal-title":"Maturitas"},{"key":"398_CR286","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12020-012-9676-1","volume":"42","author":"SC Forbes","year":"2012","unstructured":"Forbes, S. C., Little, J. P. & Candow, D. G. Exercise and nutritional interventions for improving aging muscle health. Endocrine 42, 29\u201338 (2012).","journal-title":"Endocrine"},{"key":"398_CR287","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1210\/endo.142.4.8082","volume":"142","author":"M Brink","year":"2001","unstructured":"Brink, M. et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142, 1489\u20131496 (2001).","journal-title":"Endocrinology"},{"key":"398_CR288","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/gerona\/glp097","volume":"64","author":"LA Schaap","year":"2009","unstructured":"Schaap, L. A. et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 64, 1183\u20131189 (2009).","journal-title":"J. Gerontol. Ser. A, Biol. Sci. Med. Sci."},{"key":"398_CR289","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.exger.2013.08.011","volume":"48","author":"KC DeRuisseau","year":"2013","unstructured":"DeRuisseau, K. C. et al. Aging-related changes in the iron status of skeletal muscle. Exp. Gerontol. 48, 1294\u20131302 (2013).","journal-title":"Exp. Gerontol."},{"key":"398_CR290","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.exger.2016.09.013","volume":"85","author":"TB Aydemir","year":"2016","unstructured":"Aydemir, T. B. et al. Aging amplifies multiple phenotypic defects in mice with zinc transporter Zip14 (Slc39a14) deletion. Exp. Gerontol. 85, 88\u201394 (2016).","journal-title":"Exp. Gerontol."},{"key":"398_CR291","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mus.20808","volume":"36","author":"M Altun","year":"2007","unstructured":"Altun, M. et al. Iron load and redox stress in skeletal muscle of aged rats. Muscle Nerve 36, 223\u2013233 (2007).","journal-title":"Muscle Nerve"},{"key":"398_CR292","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1113\/expphysiol.2008.046045","volume":"94","author":"TF Reardon","year":"2009","unstructured":"Reardon, T. F. & Allen, D. G. Iron injections in mice increase skeletal muscle iron content, induce oxidative stress and reduce exercise performance. Exp. Physiol. 94, 720\u2013730 (2009).","journal-title":"Exp. Physiol."},{"key":"398_CR293","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399\u2013412 (2004).","journal-title":"Cell"},{"key":"398_CR294","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin, H., Price, F. & Rudnicki, M. A. Satellite cells and the muscle stem cell niche. Physiol. Rev. 93, 23\u201367 (2013).","journal-title":"Physiol. Rev."},{"key":"398_CR295","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1242\/dev.067587","volume":"138","author":"R Sambasivan","year":"2011","unstructured":"Sambasivan, R. et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138, 3647\u20133656 (2011).","journal-title":"Development"},{"key":"398_CR296","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41419-018-0379-2","volume":"9","author":"S Sheykhansari","year":"2018","unstructured":"Sheykhansari, S. et al. Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell Death Dis. 9, 348 (2018).","journal-title":"Cell Death Dis."},{"key":"398_CR297","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165228","volume":"133","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons. J. Clin. Investig. 133, e165228 (2023).","journal-title":"J. Clin. Investig."},{"key":"398_CR298","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1113216","volume":"17","author":"X Fu","year":"2023","unstructured":"Fu, X., He, Y., Xie, Y. & Lu, Z. A conjoint analysis of bulk RNA-seq and single-nucleus RNA-seq for revealing the role of ferroptosis and iron metabolism in ALS. Front Neurosci. 17, 1113216 (2023).","journal-title":"Front Neurosci."},{"key":"398_CR299","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2019.11.110","volume":"522","author":"E Dai","year":"2020","unstructured":"Dai, E. et al. ESCRT-III-dependent membrane repair blocks ferroptosis. Biochem. Biophys. Res. Commun. 522, 415\u2013421 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"398_CR300","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.919188","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. The classification and prediction of ferroptosis-related genes in ALS: a pilot study. Front. Genet. 13, 919188 (2022).","journal-title":"Front. Genet."},{"key":"398_CR301","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92369-8","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci. Rep. 11, 12890 (2021).","journal-title":"Sci. Rep."},{"key":"398_CR302","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","volume":"29","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death Differ. 29, 1187\u20131198 (2022).","journal-title":"Cell Death Differ."},{"key":"398_CR303","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8217663","volume":"2022","author":"J Peng","year":"2022","unstructured":"Peng, J., Pan, J., Mo, J. & Peng, Y. MPO\/HOCl facilitates apoptosis and ferroptosis in the SOD1(G93A) motor neuron of amyotrophic lateral sclerosis. Oxid. Med. Cell Longev. 2022, 8217663 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"398_CR304","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12640-021-00469-0","volume":"40","author":"RC Evans","year":"2022","unstructured":"Evans, R. C. et al. The Gpx4NIKO mouse is a versatile model for testing interventions targeting ferroptotic cell death of spinal motor neurons. Neurotox. Res. 40, 373\u2013383 (2022).","journal-title":"Neurotox. Res."},{"key":"398_CR305","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D. et al. Duchenne muscular dystrophy. Nat. Rev. Dis. Prim. 7, 13 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"398_CR306","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/jcsm.12950","volume":"13","author":"FM Alves","year":"2022","unstructured":"Alves, F. M. et al. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy. J. Cachexia Sarcopenia Muscle 13, 1541\u20131553 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"398_CR307","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0006-2952(98)00055-0","volume":"56","author":"L Bornman","year":"1998","unstructured":"Bornman, L., Rossouw, H., Gericke, G. S. & Polla, B. S. Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem. Pharmacol. 56, 751\u2013757 (1998).","journal-title":"Biochem. Pharmacol."},{"key":"398_CR308","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcsm.12633","volume":"11","author":"A Dolly","year":"2020","unstructured":"Dolly, A., Dumas, J. F. & Servais, S. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know? J. Cachexia Sarcopenia Muscle 11, 1413\u20131428 (2020).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"398_CR309","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","volume":"24","author":"G Wang","year":"2018","unstructured":"Wang, G. et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat. Med. 24, 770\u2013781 (2018).","journal-title":"Nat. Med."},{"key":"398_CR310","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01439-w","volume":"37","author":"D Zhou","year":"2020","unstructured":"Zhou, D. et al. Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis. Med Oncol. 37, 113 (2020).","journal-title":"Med Oncol."},{"key":"398_CR311","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115165","volume":"403","author":"H Sakai","year":"2020","unstructured":"Sakai, H. et al. Upregulation of ubiquitinated proteins and their degradation pathway in muscle atrophy induced by cisplatin in mice. Toxicol. Appl Pharm. 403, 115165 (2020).","journal-title":"Toxicol. Appl Pharm."},{"key":"398_CR312","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/antiox11091839","volume":"11","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. PD-1 alleviates cisplatin-induced muscle atrophy by regulating inflammation and oxidative stress. Antioxidants 11, 1839 (2022).","journal-title":"Antioxidants"},{"key":"398_CR313","doi-asserted-by":"crossref","unstructured":"Guo Y. F. et al. Heat exposure promotes sarcopenia via gut microbiota-derived metabolites. Aging Cell e14370 (2024).","DOI":"10.1111\/acel.14370"},{"key":"398_CR314","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yjmcc.2022.10.004","volume":"173","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Ferroptosis in heart failure. J. Mol. Cell Cardiol. 173, 141\u2013153 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"398_CR315","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1074\/jbc.275.5.3021","volume":"275","author":"C Ferreira","year":"2000","unstructured":"Ferreira, C. et al. Early embryonic lethality of H ferritin gene deletion in mice. J. Biol. Chem. 275, 3021\u20133024 (2000).","journal-title":"J. Biol. Chem."},{"key":"398_CR316","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.3390\/cells11213511","volume":"11","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Mitochondrial cardiomyopathy: molecular epidemiology, diagnosis, models, and therapeutic management. Cells 11, 3511 (2022).","journal-title":"Cells"},{"key":"398_CR317","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cmet.2022.08.017","volume":"34","author":"S Ahola","year":"2022","unstructured":"Ahola, S. et al. OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy. Cell Metab. 34, 1875\u20131891 e1877 (2022).","journal-title":"Cell Metab."},{"key":"398_CR318","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10557-021-07220-z","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. SLC7A11\/xCT prevents cardiac hypertrophy by inhibiting ferroptosis. Cardiovasc. Drugs Ther. 36, 437\u2013447 (2022).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"398_CR319","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz, T. Systemic iron homeostasis. Physiol. Rev. 93, 1721\u20131741 (2013).","journal-title":"Physiol. Rev."},{"key":"398_CR320","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1039\/C1DT11205H","volume":"41","author":"JD Lopez-Castro","year":"2012","unstructured":"Lopez-Castro, J. D. et al. A new approach to the ferritin iron core growth: influence of the H\/L ratio on the core shape. Dalton Trans. 41, 1320\u20131324 (2012).","journal-title":"Dalton Trans."},{"key":"398_CR321","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1089\/ars.2013.5666","volume":"20","author":"R Gozzelino","year":"2014","unstructured":"Gozzelino, R. & Soares, M. P. Coupling heme and iron metabolism via ferritin H chain. Antioxid. Redox Signal. 20, 1754\u20131769 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"398_CR322","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","volume":"119","author":"CG Pham","year":"2004","unstructured":"Pham, C. G. et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119, 529\u2013542 (2004).","journal-title":"Cell"},{"key":"398_CR323","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103157","volume":"72","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis. Redox Biol. 72, 103157 (2024).","journal-title":"Redox Biol."},{"key":"398_CR324","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal, P. K. & Iliskovic, N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339, 900\u2013905 (1998).","journal-title":"N. Engl. J. Med."},{"key":"398_CR325","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.jacc.2007.02.060","volume":"49","author":"GS Panjrath","year":"2007","unstructured":"Panjrath, G. S. et al. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model. J. Am. Coll. Cardiol. 49, 2457\u20132464 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"398_CR326","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1182\/blood-2003-03-0869","volume":"102","author":"CJ Miranda","year":"2003","unstructured":"Miranda, C. J. et al. Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 102, 2574\u20132580 (2003).","journal-title":"Blood"},{"key":"398_CR327","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa, Y. et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J. Clin. Investig. 124, 617\u2013630 (2014).","journal-title":"J. Clin. Investig."},{"key":"398_CR328","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02794-w","volume":"22","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Ultrasound targeted microbubble destruction assisted exosomal delivery of siHmox1 effectively inhibits doxorubicin-induced cardiomyocyte ferroptosis. J. Nanobiotechnol. 22, 531 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"398_CR329","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00204-024-03697-3","volume":"98","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. The Bach1\/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice. Arch. Toxicol. 98, 1781\u20131794 (2024).","journal-title":"Arch. Toxicol."},{"key":"398_CR330","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00109-014-1147-0","volume":"92","author":"F Maccarinelli","year":"2014","unstructured":"Maccarinelli, F. et al. Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity. J. Mol. Med. 92, 859\u2013869 (2014).","journal-title":"J. Mol. Med."},{"key":"398_CR331","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.freeradbiomed.2024.08.001","volume":"223","author":"W Jiang","year":"2024","unstructured":"Jiang, W. et al. MG53 inhibits ferroptosis by targeting the p53\/SLC7A11\/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity. Free Radic. Biol. Med. 223, 224\u2013236 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR332","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103066","volume":"70","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation. Redox Biol. 70, 103066 (2024).","journal-title":"Redox Biol."},{"key":"398_CR333","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118582","volume":"334","author":"Z Xu","year":"2024","unstructured":"Xu, Z. et al. Total extracts from Abelmoschus manihot (L.) alleviate radiation-induced cardiomyocyte ferroptosis via regulating redox imbalances mediated by the NOX4\/xCT\/GPX4 axis. J. Ethnopharmacol. 334, 118582 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"398_CR334","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4059542","volume":"2018","author":"O Kurmus","year":"2018","unstructured":"Kurmus, O. et al. Impact of admission blood glucose on coronary collateral flow in patients with ST-elevation myocardial infarction. Cardiol. Res. Pract. 2018, 4059542 (2018).","journal-title":"Cardiol. Res. Pract."},{"key":"398_CR335","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401056R","volume":"38","author":"C Zhong","year":"2024","unstructured":"Zhong, C. et al. Single-cell sequencing combined with transcriptomics and in vivo and in vitro analysis reveals the landscape of ferroptosis in myocardial ischemia-reperfusion injury. FASEB J. 38, e70164 (2024).","journal-title":"FASEB J."},{"key":"398_CR336","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","volume":"39","author":"W Li","year":"2020","unstructured":"Li, W. et al. Ferroptosis is involved in diabetes myocardial ischemia\/reperfusion injury through endoplasmic reticulum stress. DNA cell Biol. 39, 210\u2013225 (2020).","journal-title":"DNA cell Biol."},{"key":"398_CR337","doi-asserted-by":"crossref","unstructured":"Kozhukhov S. et al. Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study. Hellenic J. Cardiol. 76, 68\u201374 (2023).","DOI":"10.1016\/j.hjc.2023.08.004"},{"key":"398_CR338","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park, T. J. et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis. 10, 835 (2019).","journal-title":"Cell Death Dis."},{"key":"398_CR339","doi-asserted-by":"publisher","first-page":"10832","DOI":"10.3390\/ijms251910832","volume":"25","author":"T Xu","year":"2024","unstructured":"Xu, T. & Chen, G. MPV17 prevents myocardial ferroptosis and ischemic cardiac injury through maintaining SLC25A10-mediated mitochondrial glutathione import. Int. J. Mol. Sci. 25, 10832 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"398_CR340","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103145","volume":"72","author":"Z Qu","year":"2024","unstructured":"Qu, Z. et al. The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury. Redox Biol. 72, 103145 (2024).","journal-title":"Redox Biol."},{"key":"398_CR341","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer, X., Salvado, L., Barroso, E. & Vazquez-Carrera, M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int. J. Cardiol. 168, 3160\u20133172 (2013).","journal-title":"Int. J. Cardiol."},{"key":"398_CR342","doi-asserted-by":"crossref","unstructured":"Liu P. et al. Ferroptosis: mechanisms and role in diabetes mellitus and its complications. Ageing Res. Rev. 94, 102201 (2024).","DOI":"10.1016\/j.arr.2024.102201"},{"key":"398_CR343","doi-asserted-by":"publisher","first-page":"e4641","DOI":"10.1210\/clinem\/dgab454","volume":"106","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Genetic support of a causal relationship between iron status and type 2 diabetes: a Mendelian randomization study. J. Clin. Endocrinol. Metab. 106, e4641\u2013e4651 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"398_CR344","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155979","volume":"159","author":"M Zhao","year":"2024","unstructured":"Zhao, M. et al. Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis. Metabolism 159, 155979 (2024).","journal-title":"Metabolism"},{"key":"398_CR345","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003921","volume":"5","author":"CE Ndumele","year":"2016","unstructured":"Ndumele, C. E. et al. Obesity and subtypes of incident cardiovascular disease. J. Am. Heart Assoc. 5, e003921 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"398_CR346","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1111\/jcmm.15318","volume":"24","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2-related programmed cell death in an AMPK-dependent manner. J. Cell Mol. Med. 24, 6670\u20136679 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"398_CR347","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112605","volume":"138","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Downregulation of the (pro)renin receptor alleviates ferroptosis-associated cardiac pathological changes via the NCOA 4-mediated ferritinophagy pathway in diabetic cardiomyopathy. Int. Immunopharmacol. 138, 112605 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"398_CR348","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177021","volume":"984","author":"YR Shen","year":"2024","unstructured":"Shen, Y. R., Cheng, L. & Zhang, D. F. TRPV1: a novel target for the therapy of diabetes and diabetic complications. Eur. J. Pharm. 984, 177021 (2024).","journal-title":"Eur. J. Pharm."},{"key":"398_CR349","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112852","volume":"140","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Dietary capsaicin attenuates cardiac injury after myocardial infarction in type 2 diabetic mice by inhibiting ferroptosis through activation of TRPV1 and Nrf2\/HMOX1 pathway. Int. Immunopharmacol. 140, 112852 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"398_CR350","doi-asserted-by":"publisher","first-page":"H508","DOI":"10.1152\/ajpheart.00559.2019","volume":"318","author":"A Sampilvanjil","year":"2020","unstructured":"Sampilvanjil, A. et al. Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 318, H508\u2013H518 (2020).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"398_CR351","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300198RRR","volume":"38","author":"X He","year":"2024","unstructured":"He, X. et al. Ferrostatin-1 inhibits ferroptosis of vascular smooth muscle cells and alleviates abdominal aortic aneurysm formation through activating the SLC7A11\/GPX4 axis. FASEB J. 38, e23401 (2024).","journal-title":"FASEB J."},{"key":"398_CR352","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41467-024-45823-w","volume":"15","author":"DY Sun","year":"2024","unstructured":"Sun, D. Y. et al. Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence. Nat. Commun. 15, 1429 (2024).","journal-title":"Nat. Commun."},{"key":"398_CR353","doi-asserted-by":"publisher","first-page":"116112","DOI":"10.1016\/j.biopha.2023.116112","volume":"171","author":"X Xu","year":"2024","unstructured":"Xu, X. et al. The mechanisms of ferroptosis and its role in atherosclerosis. Biomed. Pharmacother. 171, 116112 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"398_CR354","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-19092-1","volume":"8","author":"S Kawada","year":"2018","unstructured":"Kawada, S. et al. Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with\/without TNF-alpha. Sci. Rep. 8, 658 (2018).","journal-title":"Sci. Rep."},{"key":"398_CR355","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.kint.2022.08.031","volume":"102","author":"TB Drueke","year":"2022","unstructured":"Drueke, T. B. & Massy, Z. A. Vascular calcification in chronic kidney disease: contribution of ferroptosis? Kidney Int. 102, 1209\u20131211 (2022).","journal-title":"Kidney Int."},{"key":"398_CR356","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.kint.2022.07.034","volume":"102","author":"Y Ye","year":"2022","unstructured":"Ye, Y. et al. Repression of the antiporter SLC7A11\/glutathione\/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 102, 1259\u20131275 (2022).","journal-title":"Kidney Int."},{"key":"398_CR357","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12933-024-02224-z","volume":"23","author":"Y Aierken","year":"2024","unstructured":"Aierken, Y. et al. Inhibition of Slc39a14\/Slc39a8 reduce vascular calcification via alleviating iron overload induced ferroptosis in vascular smooth muscle cells. Cardiovasc Diabetol. 23, 186 (2024).","journal-title":"Cardiovasc Diabetol."},{"key":"398_CR358","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.7150\/ijbs.72528","volume":"18","author":"N Li","year":"2022","unstructured":"Li, N. et al. Targeting ferroptosis as a novel approach to alleviate aortic dissection. Int. J. Biol. Sci. 18, 4118\u20134134 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"398_CR359","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10020-023-00694-7","volume":"29","author":"J Shi","year":"2023","unstructured":"Shi, J. et al. Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1alpha\/HMOX1 axis. Mol. Med. 29, 91 (2023).","journal-title":"Mol. Med."},{"key":"398_CR360","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10020-022-00549-7","volume":"28","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice. Mol. Med. 28, 121 (2022).","journal-title":"Mol. Med."},{"key":"398_CR361","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41418-022-01099-5","volume":"30","author":"QX Ji","year":"2023","unstructured":"Ji, Q. X. et al. Ferroptotic stress facilitates smooth muscle cell dedifferentiation in arterial remodelling by disrupting mitochondrial homeostasis. Cell Death Differ. 30, 457\u2013474 (2023).","journal-title":"Cell Death Differ."},{"key":"398_CR362","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41420-023-01748-9","volume":"9","author":"B Yan","year":"2023","unstructured":"Yan, B. et al. Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells. Cell Death Discov. 9, 456 (2023).","journal-title":"Cell Death Discov."},{"key":"398_CR363","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bcmd.2012.10.006","volume":"50","author":"A Lal","year":"2013","unstructured":"Lal, A. et al. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol. Dis. 50, 99\u2013104 (2013).","journal-title":"Blood Cells Mol. Dis."},{"key":"398_CR364","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1182\/blood-2007-08-109306","volume":"111","author":"AR Cohen","year":"2008","unstructured":"Cohen, A. R., Glimm, E. & Porter, J. B. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood 111, 583\u2013587 (2008).","journal-title":"Blood"},{"key":"398_CR365","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1182\/blood-2014-07-586677","volume":"125","author":"Y Aydinok","year":"2015","unstructured":"Aydinok, Y. et al. Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload. Blood 125, 3868\u20133877 (2015).","journal-title":"Blood"},{"key":"398_CR366","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1182\/blood-2013-04-497842","volume":"123","author":"DJ Pennell","year":"2014","unstructured":"Pennell, D. J. et al. A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA). Blood 123, 1447\u20131454 (2014).","journal-title":"Blood"},{"key":"398_CR367","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ajh.23876","volume":"90","author":"DJ Pennell","year":"2015","unstructured":"Pennell, D. J. et al. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. Am. J. Hematol. 90, 91\u201396 (2015).","journal-title":"Am. J. Hematol."},{"key":"398_CR368","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3324\/haematol.2011.056317","volume":"97","author":"Y Aydinok","year":"2012","unstructured":"Aydinok, Y., Evans, P., Manz, C. Y. & Porter, J. B. Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response. Haematologica 97, 835\u2013841 (2012).","journal-title":"Haematologica"},{"key":"398_CR369","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2141.2009.07609.x","volume":"145","author":"A Maggio","year":"2009","unstructured":"Maggio, A. et al. Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial. Br. J. Haematol. 145, 245\u2013254 (2009).","journal-title":"Br. J. Haematol."},{"key":"398_CR370","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1182\/blood-2010-11-316646","volume":"118","author":"MD Cappellini","year":"2011","unstructured":"Cappellini, M. D. et al. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years\u2019 follow-up. Blood 118, 884\u2013893 (2011).","journal-title":"Blood"},{"key":"398_CR371","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1182\/blood-2009-11-250308","volume":"116","author":"JC Wood","year":"2010","unstructured":"Wood, J. C. et al. The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores. Blood 116, 537\u2013543 (2010).","journal-title":"Blood"},{"key":"398_CR372","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3324\/haematol.2010.032862","volume":"96","author":"JC Wood","year":"2011","unstructured":"Wood, J. C. et al. Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial. Haematologica 96, 1055\u20131058 (2011).","journal-title":"Haematologica"},{"key":"398_CR373","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-021-00618-2","volume":"22","author":"V Giannuzzi","year":"2021","unstructured":"Giannuzzi, V. et al. Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project. BMC Med. Eth. 22, 49 (2021).","journal-title":"BMC Med. Eth."},{"key":"398_CR374","doi-asserted-by":"crossref","unstructured":"Maggio, A. et al. Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Lancet Haematol. 7, e469\u2013e478 (2020).","DOI":"10.1016\/S2352-3026(20)30100-9"},{"key":"398_CR375","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3945\/ajcn.112.049163","volume":"98","author":"Y Michailidis","year":"2013","unstructured":"Michailidis, Y. et al. Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am. J. Clin. Nutr. 98, 233\u2013245 (2013).","journal-title":"Am. J. Clin. Nutr."},{"key":"398_CR376","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.117.312647","volume":"122","author":"AJ Marian","year":"2018","unstructured":"Marian, A. J. et al. Hypertrophy regression with N-acetylcysteine in hypertrophic cardiomyopathy (HALT-HCM): a randomized, placebo-controlled, double-blind pilot study. Circ. Res. 122, 1109\u20131118 (2018).","journal-title":"Circ. Res."},{"key":"398_CR377","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1210\/jc.2014-2192","volume":"99","author":"J Vidart","year":"2014","unstructured":"Vidart, J. et al. N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial. J. Clin. Endocrinol. Metab. 99, 4537\u20134545 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"398_CR378","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.amjcard.2022.04.031","volume":"176","author":"JD Pierce","year":"2022","unstructured":"Pierce, J. D. et al. Effects of ubiquinol and\/or D-ribose in patients with heart failure with preserved ejection fraction. Am. J. Cardiol. 176, 79\u201388 (2022).","journal-title":"Am. J. Cardiol."},{"key":"398_CR379","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12872-018-0796-2","volume":"18","author":"JD Pierce","year":"2018","unstructured":"Pierce, J. D. et al. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and\/or D-ribose. BMC Cardiovasc. Disord. 18, 57 (2018).","journal-title":"BMC Cardiovasc. Disord."},{"key":"398_CR380","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S0140-6736(15)60025-3","volume":"385","author":"GM Buyse","year":"2015","unstructured":"Buyse, G. M. et al. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial. Lancet 385, 1748\u20131757 (2015).","journal-title":"Lancet"},{"key":"398_CR381","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/21678421.2018.1556698","volume":"20","author":"RS Bedlack","year":"2019","unstructured":"Bedlack, R. S. et al. Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. Amyotroph. Lateral Scler. Frontotemp. Degener. 20, 285\u2013293 (2019).","journal-title":"Amyotroph. Lateral Scler. Frontotemp. Degener."},{"key":"398_CR382","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun, S. et al. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct. Target Ther. 8, 372 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"398_CR383","doi-asserted-by":"publisher","first-page":"e90105","DOI":"10.1371\/journal.pone.0090105","volume":"9","author":"TH Kim","year":"2014","unstructured":"Kim, T. H., Hwang, H. J. & Kim, S. H. Relationship between serum ferritin levels and sarcopenia in Korean females aged 60 years and older using the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008\u20132009. PloS one 9, e90105 (2014).","journal-title":"PloS one"},{"key":"398_CR384","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40520-016-0701-8","volume":"29","author":"S Perna","year":"2017","unstructured":"Perna, S. et al. Sarcopenia and sarcopenic obesity in comparison: prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly. Aging Clin. Exp. Res. 29, 1249\u20131258 (2017).","journal-title":"Aging Clin. Exp. Res."},{"key":"398_CR385","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12011-018-1332-z","volume":"186","author":"G Zhao","year":"2018","unstructured":"Zhao, G. Is iron accumulation a possible risk factor for sarcopenia? Biol. Trace Elem. Res 186, 379\u2013383 (2018).","journal-title":"Biol. Trace Elem. Res"},{"key":"398_CR386","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.3390\/nu14194023","volume":"14","author":"SJ Chung","year":"2022","unstructured":"Chung, S. J. et al. Sex-specific associations between serum ferritin and osteosarcopenic obesity in adults aged over 50 years. Nutrients 14, 4023 (2022).","journal-title":"Nutrients"},{"key":"398_CR387","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.jrn.2016.01.011","volume":"26","author":"C Nakagawa","year":"2016","unstructured":"Nakagawa, C. et al. Association of increased serum ferritin with impaired muscle strength\/quality in hemodialysis patients. J. Ren. Nutr. 26, 253\u2013257 (2016).","journal-title":"J. Ren. Nutr."},{"key":"398_CR388","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s40520-022-02242-5","volume":"34","author":"V Ho","year":"2022","unstructured":"Ho, V., Lee, C. T. & Merchant, R. A. The \u201cIron Tale\u201d- iron indices and handgrip strength in community-dwelling adults. Aging Clin. Exp. Res. 34, 3025\u20133032 (2022).","journal-title":"Aging Clin. Exp. Res."},{"key":"398_CR389","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s11255-021-02799-6","volume":"53","author":"AB Gadelha","year":"2021","unstructured":"Gadelha, A. B. et al. Effects of pre-dialysis resistance training on sarcopenia, inflammatory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial. Int. Urol. Nephrol. 53, 2137\u20132147 (2021).","journal-title":"Int. Urol. Nephrol."},{"key":"398_CR390","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2215\/CJN.01490506","volume":"1","author":"JB Wish","year":"2006","unstructured":"Wish, J. B. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin. J. Am. Soc. Nephrol. 1, S4\u2013S8 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"398_CR391","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli, J. P. F., Shah, R., Pratt, D. A. & Conrad, M. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol. Sci. 38, 489\u2013498 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"398_CR392","doi-asserted-by":"crossref","unstructured":"Moraes L. H. et al. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells. Redox Rep. 20, 109\u2013115 (2015).","DOI":"10.1179\/1351000214Y.0000000112"},{"key":"398_CR393","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. & Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26, 165\u2013176 (2016).","journal-title":"Trends Cell Biol."},{"key":"398_CR394","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","volume":"12","author":"L You","year":"2018","unstructured":"You, L. et al. Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in Parkinsonian mice. ACS Nano 12, 4123\u20134139 (2018).","journal-title":"ACS Nano"},{"key":"398_CR395","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.7150\/ijbs.58786","volume":"17","author":"C Tian","year":"2021","unstructured":"Tian, C. et al. Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int. J. Biol. Sci. 17, 1328\u20131338 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"398_CR396","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39739-5","volume":"9","author":"D Devos","year":"2019","unstructured":"Devos, D. et al. A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Sci. Rep. 9, 2918 (2019).","journal-title":"Sci. Rep."},{"key":"398_CR397","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/17482968.2012.665929","volume":"13","author":"A Ignjatovic","year":"2012","unstructured":"Ignjatovic, A. et al. Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. 13, 357\u2013362 (2012).","journal-title":"Amyotroph. Lateral Scler."},{"key":"398_CR398","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/485723","volume":"2014","author":"C Veyrat-Durebex","year":"2014","unstructured":"Veyrat-Durebex, C. et al. Iron metabolism disturbance in a French cohort of ALS patients. Biomed. Res Int 2014, 485723 (2014).","journal-title":"Biomed. Res Int"},{"key":"398_CR399","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12640-016-9677-6","volume":"31","author":"S Golko-Perez","year":"2017","unstructured":"Golko-Perez, S. et al. A novel iron chelator-radical scavenger ameliorates motor dysfunction and improves life span and mitochondrial biogenesis in SOD1(G93A) ALS mice. Neurotox. Res. 31, 230\u2013244 (2017).","journal-title":"Neurotox. Res."},{"key":"398_CR400","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1089\/ars.2017.7493","volume":"29","author":"C Moreau","year":"2018","unstructured":"Moreau, C. et al. Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid. redox Signal. 29, 742\u2013748 (2018).","journal-title":"Antioxid. redox Signal."},{"key":"398_CR401","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1007\/s00330-020-07599-7","volume":"31","author":"V Ojha","year":"2021","unstructured":"Ojha, V. et al. Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major. Eur. Radio. 31, 6184\u20136192 (2021).","journal-title":"Eur. Radio."},{"key":"398_CR402","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1182\/blood-2009-02-203323","volume":"114","author":"TV Adamkiewicz","year":"2009","unstructured":"Adamkiewicz, T. V. et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood 114, 4632\u20134638 (2009).","journal-title":"Blood"},{"key":"398_CR403","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/03630260600642542","volume":"30","author":"A Kolnagou","year":"2006","unstructured":"Kolnagou, A., Economides, C., Eracleous, E. & Kontoghiorghes, G. J. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*. Hemoglobin 30, 219\u2013227 (2006).","journal-title":"Hemoglobin"},{"key":"398_CR404","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","volume":"123","author":"JP Carpenter","year":"2011","unstructured":"Carpenter, J. P. et al. On T2* magnetic resonance and cardiac iron. Circulation 123, 1519\u20131528 (2011).","journal-title":"Circulation"},{"key":"398_CR405","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00330-022-09120-8","volume":"33","author":"A Meloni","year":"2022","unstructured":"Meloni, A. et al. Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major. Eur. Radio. 33, 1266\u20131276 (2022).","journal-title":"Eur. Radio."},{"key":"398_CR406","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10554-017-1219-7","volume":"34","author":"F Pizzino","year":"2018","unstructured":"Pizzino, F. et al. Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study. Int. J. Cardiovasc. Imaging 34, 263\u2013271 (2018).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"398_CR407","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/17474086.2018.1476134","volume":"11","author":"N Siri-Angkul","year":"2018","unstructured":"Siri-Angkul, N., Chattipakorn, S. C. & Chattipakorn, N. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients. Expert Rev. Hematol. 11, 471\u2013479 (2018).","journal-title":"Expert Rev. Hematol."},{"key":"398_CR408","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1097\/HS9.0000000000000732","volume":"6","author":"D Farmakis","year":"2022","unstructured":"Farmakis, D. et al. 2021 Thalassaemia International Federation Guidelines for the management of transfusion-dependent thalassemia. Hemasphere 6, e732 (2022).","journal-title":"Hemasphere"},{"key":"398_CR409","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","volume":"128","author":"DJ Pennell","year":"2013","unstructured":"Pennell, D. J. et al. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation 128, 281\u2013308 (2013).","journal-title":"Circulation"},{"key":"398_CR410","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.ijcard.2014.09.139","volume":"177","author":"A Meloni","year":"2014","unstructured":"Meloni, A. et al. Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major. Int. J. Cardiol. 177, 1012\u20131019 (2014).","journal-title":"Int. J. Cardiol."},{"key":"398_CR411","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/mrm.22410","volume":"64","author":"A Meloni","year":"2010","unstructured":"Meloni, A. et al. Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients. Magn. Reson. Med. 64, 211\u2013219 (2010).","journal-title":"Magn. Reson. Med."},{"key":"398_CR412","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00330-020-06668-1","volume":"30","author":"A Meloni","year":"2020","unstructured":"Meloni, A. et al. CMR for myocardial iron overload quantification: calibration curve from the MIOT Network. Eur. Radio. 30, 3217\u20133225 (2020).","journal-title":"Eur. Radio."},{"key":"398_CR413","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.3390\/ijms21228771","volume":"21","author":"VM Pinto","year":"2020","unstructured":"Pinto, V. M. & Forni, G. L. Management of iron overload in beta-thalassemia patients: clinical practice update based on case series. Int J. Mol. Sci. 21, 8771 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"398_CR414","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/SHK.0000000000001869","volume":"57","author":"T Jin","year":"2022","unstructured":"Jin, T. et al. UAMC-3203 or\/and deferoxamine improve post-resuscitation myocardial dysfunction through suppressing ferroptosis in a rat model of cardiac arrest. Shock 57, 344\u2013350 (2022).","journal-title":"Shock"},{"key":"398_CR415","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00210-020-01932-z","volume":"394","author":"LJ Tang","year":"2021","unstructured":"Tang, L. J. et al. Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia\/reperfusion. Naunyn Schmiedebergs Arch. Pharm. 394, 401\u2013410 (2021).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"398_CR416","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ajh.23386","volume":"88","author":"V Viprakasit","year":"2013","unstructured":"Viprakasit, V. et al. Deferiprone (GPO-L-ONE((R))) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand. Am. J. Hematol. 88, 251\u2013260 (2013).","journal-title":"Am. J. Hematol."},{"key":"398_CR417","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/03630269.2022.2072326","volume":"46","author":"T Kittipoom","year":"2022","unstructured":"Kittipoom, T. et al. The long-term efficacy of deferiprone in thalassemia patients with iron overload: real-world data from the registry database. Hemoglobin 46, 75\u201380 (2022).","journal-title":"Hemoglobin"},{"key":"398_CR418","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ajh.24966","volume":"93","author":"MS Elalfy","year":"2018","unstructured":"Elalfy, M. S. et al. Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: a randomized controlled trial. Am. J. Hematol. 93, 262\u2013268 (2018).","journal-title":"Am. J. Hematol."},{"key":"398_CR419","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2019.036","volume":"11","author":"J Li","year":"2019","unstructured":"Li, J., Lin, Y., Li, X. & Zhang, J. Economic evaluation of chelation regimens for beta-thalassemia major: a systematic review. Mediterr. J. Hematol. Infect. Dis. 11, e2019036 (2019).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"398_CR420","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/17512433.2018.1473760","volume":"11","author":"K Sridharan","year":"2018","unstructured":"Sridharan, K. & Sivaramakrishnan, G. Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis. Expert Rev. Clin. Pharm. 11, 641\u2013650 (2018).","journal-title":"Expert Rev. Clin. Pharm."},{"key":"398_CR421","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2015.08.017","volume":"765","author":"S Wongjaikam","year":"2015","unstructured":"Wongjaikam, S. et al. Current and future treatment strategies for iron overload cardiomyopathy. Eur. J. Pharm. 765, 86\u201393 (2015).","journal-title":"Eur. J. Pharm."},{"key":"398_CR422","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00277-019-03618-w","volume":"98","author":"F Koohi","year":"2019","unstructured":"Koohi, F., Kazemi, T. & Miri-Moghaddam, E. Cardiac complications and iron overload in beta-thalassemia major patients-a systematic review and meta-analysis. Ann. Hematol. 98, 1323\u20131331 (2019).","journal-title":"Ann. Hematol."},{"key":"398_CR423","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ajh.24914","volume":"92","author":"AT Taher","year":"2017","unstructured":"Taher, A. T. et al. Safety and pharmacokinetics of the oral iron chelator SP-420 in beta-thalassemia. Am. J. Hematol. 92, 1356\u20131361 (2017).","journal-title":"Am. J. Hematol."},{"key":"398_CR424","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","volume":"61","author":"L Devisscher","year":"2018","unstructured":"Devisscher, L. et al. Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy. J. Med. Chem. 61, 10126\u201310140 (2018).","journal-title":"J. Med. Chem."},{"key":"398_CR425","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28718-6","volume":"13","author":"S Van Coillie","year":"2022","unstructured":"Van Coillie, S. et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat. Commun. 13, 1046 (2022).","journal-title":"Nat. Commun."},{"key":"398_CR426","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbrc.2019.10.006","volume":"520","author":"Y Feng","year":"2019","unstructured":"Feng, Y. et al. Liproxstatin-1 protects the mouse myocardium against ischemia\/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels. Biochem. Biophys. Res. Commun. 520, 606\u2013611 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"398_CR427","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1073\/pnas.1916198117","volume":"117","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ. Proc. Natl. Acad. Sci. USA 117, 4792\u20134801 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"398_CR428","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114747","volume":"383","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Role of polypyrimidine tract-binding protein 1\/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia. Toxicol. Appl. Pharm. 383, 114747 (2019).","journal-title":"Toxicol. Appl. Pharm."},{"key":"398_CR429","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2017.35","volume":"3","author":"XN Wu","year":"2017","unstructured":"Wu, X. N. et al. Methylation of transcription factor YY2 regulates its transcriptional activity and cell proliferation. Cell Discov. 3, 17035 (2017).","journal-title":"Cell Discov."},{"key":"398_CR430","doi-asserted-by":"publisher","first-page":"25255","DOI":"10.1074\/jbc.M112.357053","volume":"287","author":"L Zhou","year":"2012","unstructured":"Zhou, L. et al. A novel target of microRNA-29, Ring1 and YY1-binding protein (Rybp), negatively regulates skeletal myogenesis. J. Biol. Chem. 287, 25255\u201325265 (2012).","journal-title":"J. Biol. Chem."},{"key":"398_CR431","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899727","volume":"38","author":"F Chen","year":"2019","unstructured":"Chen, F. et al. YY1 regulates skeletal muscle regeneration through controlling metabolic reprogramming of satellite cells. EMBO J. 38, e99727 (2019).","journal-title":"EMBO J."},{"key":"398_CR432","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104836","volume":"9","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Homeostasis imbalance of YY2 and YY1 promotes tumor growth by manipulating ferroptosis. Adv. Sci. 9, e2104836 (2022).","journal-title":"Adv. Sci."},{"key":"398_CR433","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-213X-9-45","volume":"9","author":"D Drews","year":"2009","unstructured":"Drews, D., Klar, M., Dame, C. & Brauer, A. U. Developmental expression profile of the YY2 gene in mice. BMC Dev. Biol. 9, 45 (2009).","journal-title":"BMC Dev. Biol."},{"key":"398_CR434","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbrc.2018.03.113","volume":"499","author":"YT Bai","year":"2018","unstructured":"Bai, Y. T. et al. ENPP2 protects cardiomyocytes from erastin-induced ferroptosis. Biochem. Biophys. Res. Commun. 499, 44\u201351 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"398_CR435","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11596-022-2683-4","volume":"43","author":"XM Xie","year":"2023","unstructured":"Xie, X. M. et al. LRP6 bidirectionally regulates insulin sensitivity through insulin receptor and S6K signaling in rats with CG-IUGR. Curr. Med. Sci. 43, 274\u2013283 (2023).","journal-title":"Curr. Med. Sci."},{"key":"398_CR436","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2013.01.009","volume":"17","author":"R Singh","year":"2013","unstructured":"Singh, R. et al. LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab. 17, 197\u2013209 (2013).","journal-title":"Cell Metab."},{"key":"398_CR437","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8963987","volume":"2021","author":"RL Li","year":"2021","unstructured":"Li, R. L., Fan, C. H., Gong, S. Y. & Kang, S. Effect and mechanism of LRP6 on cardiac myocyte ferroptosis in myocardial infarction. Oxid. Med. Cell Longev. 2021, 8963987 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"key":"398_CR438","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun, T., Liu, Z. & Yang, Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol. Cancer 19, 146 (2020).","journal-title":"Mol. Cancer"},{"key":"398_CR439","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2020.10.307","volume":"162","author":"LJ Tang","year":"2021","unstructured":"Tang, L. J. et al. Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53\/TfR1 pathway in the rat hearts after ischemia\/reperfusion. Free Radic. Biol. Med. 162, 339\u2013352 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR440","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114179","volume":"184","author":"X Wu","year":"2022","unstructured":"Wu, X. & Xu, L. The RNA-binding protein HuR in human cancer: a friend or foe? Adv. Drug Deliv. Rev. 184, 114179 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"398_CR441","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10020-021-00271-w","volume":"27","author":"HY Chen","year":"2021","unstructured":"Chen, H. Y. et al. ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia\/reperfusion injury by regulating autophagy. Mol. Med. 27, 14 (2021).","journal-title":"Mol. Med."},{"key":"398_CR442","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.molcel.2016.02.007","volume":"61","author":"JA Pan","year":"2016","unstructured":"Pan, J. A. et al. TRIM21 ubiquitylates SQSTM1\/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol. Cell 61, 720\u2013733 (2016).","journal-title":"Mol. Cell"},{"key":"398_CR443","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103456","volume":"69","author":"K Hou","year":"2021","unstructured":"Hou, K. et al. Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin. EBioMedicine 69, 103456 (2021).","journal-title":"EBioMedicine"},{"key":"398_CR444","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yjmcc.2021.08.006","volume":"161","author":"H Kitakata","year":"2021","unstructured":"Kitakata, H. et al. MITOL\/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis. J. Mol. Cell Cardiol. 161, 116\u2013129 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"398_CR445","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10565-021-09660-7","volume":"39","author":"S Zhuang","year":"2021","unstructured":"Zhuang, S. et al. METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol. Toxicol. 39, 1015\u20131035 (2021).","journal-title":"Cell Biol. Toxicol."},{"key":"398_CR446","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41419-020-02948-2","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Acyl-CoA thioesterase 1 prevents cardiomyocytes from Doxorubicin-induced ferroptosis via shaping the lipid composition. Cell Death Dis. 11, 756 (2020).","journal-title":"Cell Death Dis."},{"key":"398_CR447","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of mammalian iron metabolism. Cell 142, 24\u201338 (2010).","journal-title":"Cell"},{"key":"398_CR448","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206007","volume":"10","author":"J Pan","year":"2023","unstructured":"Pan, J. et al. The Imbalance of p53-Park7 signaling axis induces iron homeostasis dysfunction in doxorubicin-challenged cardiomyocytes. Adv. Sci. 10, e2206007 (2023).","journal-title":"Adv. Sci."},{"key":"398_CR449","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102825","volume":"65","author":"B Wang","year":"2023","unstructured":"Wang, B. et al. EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2. Redox Biol. 65, 102825 (2023).","journal-title":"Redox Biol."},{"key":"398_CR450","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1080\/15548627.2021.1904488","volume":"17","author":"H Song","year":"2021","unstructured":"Song, H. et al. CREG1 improves the capacity of the skeletal muscle response to exercise endurance via modulation of mitophagy. Autophagy 17, 4102\u20134118 (2021).","journal-title":"Autophagy"},{"key":"398_CR451","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101444","volume":"32","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. DNA hypermethylation: a novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction. Redox Biol. 32, 101444 (2020).","journal-title":"Redox Biol."},{"key":"398_CR452","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103293","volume":"75","author":"D Liu","year":"2024","unstructured":"Liu, D. et al. CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes. Redox Biol. 75, 103293 (2024).","journal-title":"Redox Biol."},{"key":"398_CR453","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2023.03.003","volume":"201","author":"M Zhu","year":"2023","unstructured":"Zhu, M. et al. STAT3 signaling promotes cardiac injury by upregulating NCOA4-mediated ferritinophagy and ferroptosis in high-fat-diet fed mice. Free Radic. Biol. Med. 201, 111\u2013125 (2023).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR454","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2023.11.032","volume":"210","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. Upregulation of NF-kappaB by USP24 aggravates ferroptosis in diabetic cardiomyopathy. Free Radic. Biol. Med. 210, 352\u2013366 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR455","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.10.010","volume":"150","author":"N Wang","year":"2021","unstructured":"Wang, N. et al. HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J. Mol. Cell Cardiol. 150, 65\u201376 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"398_CR456","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/jamaneurol.2016.3712","volume":"74","author":"A Freischmidt","year":"2017","unstructured":"Freischmidt, A. et al. Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol. 74, 110\u2013113 (2017).","journal-title":"JAMA Neurol."},{"key":"398_CR457","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2018.08.035","volume":"174","author":"H Yu","year":"2018","unstructured":"Yu, H. & Cleveland, D. W. Tuning apoptosis and neuroinflammation: TBK1 restrains RIPK1. Cell 174, 1339\u20131341 (2018).","journal-title":"Cell"},{"key":"398_CR458","first-page":"7386","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. hTBK1-c.978T>A mutation promotes the ferroptosis in NSC-34 cells via mediation of KEAP1\/NRF2\/p62 signaling. Am. J. Transl. Res. 12, 7386\u20137394 (2020).","journal-title":"Am. J. Transl. Res."},{"key":"398_CR459","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6686","volume":"6","author":"A Parent","year":"2015","unstructured":"Parent, A. et al. Mammalian frataxin directly enhances sulfur transfer of NFS1 persulfide to both ISCU and free thiols. Nat. Commun. 6, 5686 (2015).","journal-title":"Nat. Commun."},{"key":"398_CR460","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101483","volume":"32","author":"J Du","year":"2020","unstructured":"Du, J. et al. Identification of Frataxin as a regulator of ferroptosis. Redox Biol. 32, 101483 (2020).","journal-title":"Redox Biol."},{"key":"398_CR461","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.freeradbiomed.2023.06.016","volume":"205","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Frataxin inhibits the sensitivity of the myocardium to ferroptosis by regulating iron homeostasis. Free Radic. Biol. Med. 205, 305\u2013317 (2023).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR462","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-023-00927-1","volume":"30","author":"J Ju","year":"2023","unstructured":"Ju, J. et al. Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia\/reperfusion injury by interacting with NAMPT. J. Biomed. Sci. 30, 45 (2023).","journal-title":"J. Biomed. Sci."},{"key":"398_CR463","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamacardio.2016.4471","volume":"1","author":"BA Maron","year":"2016","unstructured":"Maron, B. A. & Galie, N. Diagnosis, treatment, and clinical management of pulmonary arterial hypertension in the contemporary era: a review. JAMA Cardiol. 1, 1056\u20131065 (2016).","journal-title":"JAMA Cardiol."},{"key":"398_CR464","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110900","volume":"27","author":"S He","year":"2024","unstructured":"He, S. et al. Superenhancer-driven circRNA Myst4 involves in pulmonary artery smooth muscle cell ferroptosis in pulmonary hypertension. iScience 27, 110900 (2024).","journal-title":"iScience"},{"key":"398_CR465","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/mmr.2020.11114","volume":"22","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Dexmedetomidine alleviated sepsisinduced myocardial ferroptosis and septic heart injury. Mol. Med. Rep. 22, 175\u2013184 (2020).","journal-title":"Mol. Med. Rep."},{"key":"398_CR466","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1021\/acs.jafc.4c03239","volume":"72","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. beta-Caryophyllene confers cardioprotection by scavenging radicals and blocking ferroptosis. J. Agric Food Chem. 72, 18003\u201318012 (2024).","journal-title":"J. Agric Food Chem."},{"key":"398_CR467","doi-asserted-by":"publisher","first-page":"53671","DOI":"10.1021\/acsami.1c18061","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Targeting ferroptosis by polydopamine nanoparticles protects heart against ischemia\/reperfusion injury. ACS Appl. Mater. Interfaces 13, 53671\u201353682 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"398_CR468","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.2147\/IJN.S463121","volume":"19","author":"L Tan","year":"2024","unstructured":"Tan, L. et al. The new nano-resuscitation solution (TPP-MR) attenuated myocardial injury in hemorrhagic shock rats by inhibiting ferroptosis. Int. J. Nanomed. 19, 7567\u20137583 (2024).","journal-title":"Int. J. Nanomed."},{"key":"398_CR469","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/SHK.0000000000001751","volume":"56","author":"Z Lv","year":"2021","unstructured":"Lv, Z. et al. Etomidate attenuates the ferroptosis in myocardial ischemia\/reperfusion rat model via Nrf2\/HO-1 pathway. Shock 56, 440\u2013449 (2021).","journal-title":"Shock"},{"key":"398_CR470","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/2211-5463.13276","volume":"11","author":"XJ Liu","year":"2021","unstructured":"Liu, X. J. et al. Icariin inhibits hypoxia\/reoxygenation-induced ferroptosis of cardiomyocytes via regulation of the Nrf2\/HO-1 signaling pathway. FEBS Open Bio 11, 2966\u20132976 (2021).","journal-title":"FEBS Open Bio"},{"key":"398_CR471","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s11010-021-04112-6","volume":"476","author":"LF Luo","year":"2021","unstructured":"Luo, L. F. et al. Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling. Mol. Cell Biochem. 476, 2603\u20132611 (2021).","journal-title":"Mol. Cell Biochem."},{"key":"398_CR472","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1080\/21655979.2021.1995994","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) \/System xc-\/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 12, 10924\u201310934 (2021).","journal-title":"Bioengineered"},{"key":"398_CR473","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8880141","volume":"2021","author":"X Shan","year":"2021","unstructured":"Shan, X. et al. The protective effect of cyanidin-3-glucoside on myocardial ischemia-reperfusion injury through ferroptosis. Oxid. Med Cell Longev. 2021, 8880141 (2021).","journal-title":"Oxid. Med Cell Longev."},{"key":"398_CR474","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.05.012","volume":"221","author":"D Yao","year":"2024","unstructured":"Yao, D. et al. Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2\/HO-1\/SLC7a11\/GPX4 axis in mice. Free Radic. Biol. Med. 221, 1\u201312 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR475","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118214","volume":"330","author":"YT Wu","year":"2024","unstructured":"Wu, Y. T. et al. Salvia miltiorrhiza suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling. J. Ethnopharmacol. 330, 118214 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"398_CR476","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1039\/C5NR00352K","volume":"7","author":"S Geninatti Crich","year":"2015","unstructured":"Geninatti Crich, S. et al. Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells. Nanoscale 7, 6527\u20136533 (2015).","journal-title":"Nanoscale"},{"key":"398_CR477","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.1002\/jcp.26954","volume":"233","author":"M Tang","year":"2018","unstructured":"Tang, M., Chen, Z., Wu, D. & Chen, L. Ferritinophagy\/ferroptosis: Iron-related newcomers in human diseases. J. Cell Physiol. 233, 9179\u20139190 (2018).","journal-title":"J. Cell Physiol."},{"key":"398_CR478","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1021\/acsnano.9b09186","volume":"14","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Tailored reconstituted lipoprotein for site-specific and mitochondria-targeted cyclosporine a delivery to treat traumatic brain injury. ACS Nano 14, 6636\u20136648 (2020).","journal-title":"ACS Nano"},{"key":"398_CR479","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.actbio.2023.02.025","volume":"160","author":"W Qian","year":"2023","unstructured":"Qian, W. et al. Cyclosporine A-loaded apoferritin alleviates myocardial ischemia-reperfusion injury by simultaneously blocking ferroptosis and apoptosis of cardiomyocytes. Acta Biomater. 160, 265\u2013280 (2023).","journal-title":"Acta Biomater."},{"key":"398_CR480","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-017-3175-x","volume":"441","author":"SK Kondru","year":"2018","unstructured":"Kondru, S. K., Potnuri, A. G., Allakonda, L. & Konduri, P. Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model. Mol. Cell Biochem. 441, 77\u201388 (2018).","journal-title":"Mol. Cell Biochem."},{"key":"398_CR481","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2023.04.008","volume":"204","author":"B Leng","year":"2023","unstructured":"Leng, B. et al. Targeting the Na(+)\/K(+) ATPase DR-region with DR-Ab improves doxorubicin-induced cardiotoxicity. Free Radic. Biol. Med. 204, 38\u201353 (2023).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR482","doi-asserted-by":"crossref","unstructured":"Zhang P. et al. Baicalin attenuates diabetic cardiomyopathy in vivo and in vitro by inhibiting autophagy and cell death through senp1\/sirt3 signaling pathway activation. Antioxid. Redox Signal. (2024).","DOI":"10.1089\/ars.2023.0457"},{"key":"398_CR483","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jconrel.2023.12.034","volume":"366","author":"Y Zeng","year":"2024","unstructured":"Zeng, Y. et al. Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity. J. Control Release 366, 838\u2013848 (2024).","journal-title":"J. Control Release"},{"key":"398_CR484","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2337\/db06-0267","volume":"56","author":"B Askari","year":"2007","unstructured":"Askari, B. et al. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes 56, 1143\u20131152 (2007).","journal-title":"Diabetes"},{"key":"398_CR485","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1096\/fj.202001758R","volume":"34","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion. FASEB J. 34, 16262\u201316275 (2020).","journal-title":"FASEB J."},{"key":"398_CR486","doi-asserted-by":"publisher","DOI":"10.1177\/17590914211010647","volume":"13","author":"ZL Jin","year":"2021","unstructured":"Jin, Z. L. et al. Paeonol inhibits the progression of intracerebral haemorrhage by mediating the HOTAIR\/UPF1\/ACSL4 axis. ASN Neuro 13, 17590914211010647 (2021).","journal-title":"ASN Neuro"},{"key":"398_CR487","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jare.2022.07.002","volume":"47","author":"M Ding","year":"2022","unstructured":"Ding, M. et al. Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCepsilon-Stat3 pathway. J. Adv. Res. 47, 151\u2013162 (2022).","journal-title":"J. Adv. Res."},{"key":"398_CR488","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133792","volume":"276","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Fucoidan alleviates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via Nrf2\/GPX4 pathway. Int J. Biol. Macromol. 276, 133792 (2024).","journal-title":"Int J. Biol. Macromol."},{"key":"398_CR489","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/CIRCULATIONAHA.123.067517","volume":"150","author":"D Li","year":"2024","unstructured":"Li, D. et al. Spexin diminishes atrial fibrillation vulnerability by acting on galanin receptor 2. Circulation 150, 111\u2013127 (2024).","journal-title":"Circulation"},{"key":"398_CR490","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1111\/bph.16484","volume":"181","author":"W Ou","year":"2024","unstructured":"Ou, W. et al. Spexin inhibits excessive autophagy-induced ferroptosis to alleviate doxorubicin-induced cardiotoxicity by upregulating Beclin 1. Br. J. Pharm. 181, 4195\u20134213 (2024).","journal-title":"Br. J. Pharm."},{"key":"398_CR491","doi-asserted-by":"publisher","first-page":"e2310227","DOI":"10.1002\/advs.202310227","volume":"11","author":"J Cui","year":"2024","unstructured":"Cui, J. et al. Protosappanin a protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4\/FTH1 axis-dependent ferroptosis. Adv. Sci. 11, e2310227 (2024).","journal-title":"Adv. Sci."},{"key":"398_CR492","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","volume":"15","author":"R Ferrari","year":"2018","unstructured":"Ferrari, R. et al. Expert consensus document: A \u2018diamond\u2019 approach to personalized treatment of angina. Nat. Rev. Cardiol. 15, 120\u2013132 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"398_CR493","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107057","volume":"200","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Nicorandil alleviates cardiac microvascular ferroptosis in diabetic cardiomyopathy: role of the mitochondria-localized AMPK-Parkin-ACSL4 signaling pathway. Pharm. Res. 200, 107057 (2024).","journal-title":"Pharm. Res."},{"key":"398_CR494","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10753-023-01954-8","volume":"47","author":"JS Lu","year":"2024","unstructured":"Lu, J. S., Wang, J. H., Han, K. & Li, N. Nicorandil regulates ferroptosis and mitigates septic cardiomyopathy via TLR4\/SLC7A11 signaling pathway. Inflammation 47, 975\u2013988 (2024).","journal-title":"Inflammation"},{"key":"398_CR495","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jare.2023.10.011","volume":"63","author":"C Jiang","year":"2024","unstructured":"Jiang, C. et al. Ceria nanozyme coordination with curcumin for treatment of sepsis-induced cardiac injury by inhibiting ferroptosis and inflammation. J. Adv. Res. 63, 159\u2013170 (2024).","journal-title":"J. Adv. Res."},{"key":"398_CR496","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2021.01.033","volume":"165","author":"WQ Ma","year":"2021","unstructured":"Ma, W. Q., Sun, X. J., Zhu, Y. & Liu, N. F. Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic. Biol. Med. 165, 229\u2013242 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"398_CR497","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41421-023-00595-3","volume":"9","author":"Z Cai","year":"2023","unstructured":"Cai, Z. et al. Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis. Cell Discov. 9, 104 (2023).","journal-title":"Cell Discov."},{"key":"398_CR498","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2174\/1389450121666200220123305","volume":"21","author":"S Spasic","year":"2020","unstructured":"Spasic, S. et al. Edaravone may prevent ferroptosis in ALS. Curr. Drug Targets 21, 776\u2013780 (2020).","journal-title":"Curr. Drug Targets"},{"key":"398_CR499","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111592","volume":"384","author":"T Homma","year":"2019","unstructured":"Homma, T., Kobayashi, S., Sato, H. & Fujii, J. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro. Exp. Cell Res. 384, 111592 (2019).","journal-title":"Exp. Cell Res."},{"key":"398_CR500","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122613","volume":"309","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Nanoparticles targeting OPN loaded with BY1 inhibits vascular restenosis by inducing FTH1-dependent ferroptosis in vascular smooth muscle cells. Biomaterials 309, 122613 (2024).","journal-title":"Biomaterials"},{"key":"398_CR501","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01369-w","volume":"22","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases. Cell Commun. Signal 22, 6 (2024).","journal-title":"Cell Commun. Signal"},{"key":"398_CR502","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-024-01799-6","volume":"10","author":"YC Yang","year":"2024","unstructured":"Yang, Y. C. et al. Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy. Cell Death Discov. 10, 23 (2024).","journal-title":"Cell Death Discov."},{"key":"398_CR503","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10565-020-09530-8","volume":"37","author":"Y Song","year":"2021","unstructured":"Song, Y. et al. Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol. Toxicol. 37, 51\u201364 (2021).","journal-title":"Cell Biol. Toxicol."},{"key":"398_CR504","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02618-x","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Cardiac-derived extracellular vesicles improve mitochondrial function to protect the heart against ischemia\/reperfusion injury by delivering ATP5a1. J. Nanobiotechnol. 22, 385 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"398_CR505","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02800-1","volume":"22","author":"D Guo","year":"2024","unstructured":"Guo, D. et al. Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction. J. Nanobiotechnol. 22, 527 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"398_CR506","doi-asserted-by":"crossref","unstructured":"Jung H. et al. Roles of extracellular vesicles from mesenchymal stem cells in regeneration. Mol Cells 47, 100151 (2024).","DOI":"10.1016\/j.mocell.2024.100151"},{"key":"398_CR507","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02821-w","volume":"22","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. 3D-printing hydrogel programmed released exosomes to restore aortic medial degeneration through inhibiting VSMC ferroptosis in aortic dissection. J. Nanobiotechnol. 22, 600 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"398_CR508","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai, T. T. et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat. Chem. 9, 1025\u20131033 (2017).","journal-title":"Nat. Chem."},{"key":"398_CR509","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1021\/acs.inorgchem.0c01412","volume":"59","author":"J Gao","year":"2020","unstructured":"Gao, J. et al. Reversible FRET fluorescent probe for ratiometric tracking of endogenous Fe(3+) in ferroptosis. Inorg. Chem. 59, 10920\u201310927 (2020).","journal-title":"Inorg. Chem."},{"key":"398_CR510","doi-asserted-by":"publisher","first-page":"14338","DOI":"10.1021\/jacs.6b08016","volume":"138","author":"AT Aron","year":"2016","unstructured":"Aron, A. T., Loehr, M. O., Bogena, J. & Chang, C. J. An endoperoxide reactivity-based FRET probe for ratiometric fluorescence imaging of labile iron pools in living cells. J. Am. Chem. Soc. 138, 14338\u201314346 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"398_CR511","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1039\/C8MT00212F","volume":"11","author":"T Hirayama","year":"2019","unstructured":"Hirayama, T., Miki, A. & Nagasawa, H. Organelle-specific analysis of labile Fe(ii) during ferroptosis by using a cocktail of various colour organelle-targeted fluorescent probes. Metallomics 11, 111\u2013117 (2019).","journal-title":"Metallomics"},{"key":"398_CR512","doi-asserted-by":"crossref","unstructured":"Li, H. et al. Ferroptosis accompanied by (*)OH generation and cytoplasmic viscosity increase revealed via dual-functional fluorescence probe. J. Am. Chem. Soc. 141, 18301\u201318307 (2019).","DOI":"10.1021\/jacs.9b09722"},{"key":"398_CR513","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1021\/jacs.1c08485","volume":"144","author":"K Kawai","year":"2022","unstructured":"Kawai, K. et al. Molecular imaging of labile heme in living cells using a small molecule fluorescent probe. J. Am. Chem. Soc. 144, 3793\u20133803 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"398_CR514","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.chembiol.2021.11.001","volume":"29","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. PALP: a rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ. Cell Chem. Biol. 29, 157\u2013170 e156 (2022).","journal-title":"Cell Chem. Biol."},{"key":"398_CR515","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01434-3","volume":"21","author":"X Li","year":"2022","unstructured":"Li, X. et al. Proteolysis-targeting chimeras (PROTACs) in cancer therapy. Mol. Cancer 21, 99 (2022).","journal-title":"Mol. Cancer"},{"key":"398_CR516","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1039\/D2CS00200K","volume":"51","author":"RG Guenette","year":"2022","unstructured":"Guenette, R. G. et al. Target and tissue selectivity of PROTAC degraders. Chem. Soc. Rev. 51, 5740\u20135756 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"398_CR517","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202206277","volume":"61","author":"T Luo","year":"2022","unstructured":"Luo, T. et al. Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo. Angew. Chem. Int Ed. Engl. 61, e202206277 (2022).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"398_CR518","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","volume":"79","author":"M Shirley","year":"2019","unstructured":"Shirley, M. Amikacin liposome inhalation suspension: a review in mycobacterium avium complex lung disease. Drugs 79, 555\u2013562 (2019).","journal-title":"Drugs"},{"key":"398_CR519","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1107\/S2059798320016125","volume":"77","author":"D Moosmayer","year":"2021","unstructured":"Moosmayer, D. et al. Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162. Acta Crystallogr. D. Struct. Biol. 77, 237\u2013248 (2021).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"398_CR520","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.1021\/acs.jmedchem.2c00855","volume":"65","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. PDTAC: targeted photodegradation of GPX4 triggers ferroptosis and potent antitumor immunity. J. Med. Chem. 65, 12176\u201312187 (2022).","journal-title":"J. Med. Chem."},{"key":"398_CR521","doi-asserted-by":"publisher","first-page":"630","DOI":"10.20892\/j.issn.2095-3941.2019.0158","volume":"16","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer? Cancer Biol. Med. 16, 630\u2013646 (2019).","journal-title":"Cancer Biol. Med."},{"key":"398_CR522","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","volume":"49","author":"C Nelke","year":"2019","unstructured":"Nelke, C. et al. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 49, 381\u2013388 (2019).","journal-title":"EBioMedicine"},{"key":"398_CR523","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coph.2017.05.005","volume":"34","author":"J Giudice","year":"2017","unstructured":"Giudice, J. & Taylor, J. M. Muscle as a paracrine and endocrine organ. Curr. Opin. Pharm. 34, 49\u201355 (2017).","journal-title":"Curr. Opin. Pharm."},{"key":"398_CR524","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00432-018-2699-0","volume":"144","author":"S Codenotti","year":"2018","unstructured":"Codenotti, S. et al. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines. J. Cancer Res. Clin. Oncol. 144, 1717\u20131730 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"398_CR525","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41418-022-01089-7","volume":"30","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1. Cell Death Differ. 30, 369\u2013382 (2023).","journal-title":"Cell Death Differ."},{"key":"398_CR526","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/21678421.2014.984723","volume":"16","author":"XW Su","year":"2015","unstructured":"Su, X. W. et al. Serum ferritin is elevated in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 102\u2013107 (2015).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"398_CR527","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.806081","volume":"10","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT\/GPx4 axis. Front. Cell Dev. Biol. 10, 806081 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"398_CR528","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1096\/fj.201900077R","volume":"33","author":"M Guerrero-Hue","year":"2019","unstructured":"Guerrero-Hue, M. et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 33, 8961\u20138975 (2019).","journal-title":"FASEB J."},{"key":"398_CR529","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117396119","volume":"119","author":"N Ta","year":"2022","unstructured":"Ta, N. et al. Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy. Proc. Natl Acad. Sci. USA 119, e2117396119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"398_CR530","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.808480","volume":"12","author":"D Li","year":"2021","unstructured":"Li, D. et al. Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1\/Nrf2 signaling pathway activation. Front Pharm. 12, 808480 (2021).","journal-title":"Front Pharm."},{"key":"398_CR531","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1011669","volume":"13","author":"S Du","year":"2022","unstructured":"Du, S. et al. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front. Endocrinol. 13, 1011669 (2022).","journal-title":"Front. Endocrinol."},{"key":"398_CR532","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3159717","volume":"2022","author":"Z Wei","year":"2022","unstructured":"Wei, Z., Shaohuan, Q., Pinfang, K. & Chao, S. Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway. Cardiovasc. Ther. 2022, 3159717 (2022).","journal-title":"Cardiovasc. Ther."},{"key":"398_CR533","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155365","volume":"128","author":"B Yang","year":"2024","unstructured":"Yang, B. et al. Salidroside pretreatment alleviates ferroptosis induced by myocardial ischemia\/reperfusion through mitochondrial superoxide-dependent AMPKalpha2 activation. Phytomedicine 128, 155365 (2024).","journal-title":"Phytomedicine"},{"key":"398_CR534","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1039\/D1CC06611K","volume":"58","author":"W Xing","year":"2022","unstructured":"Xing, W. et al. A PET-based fluorescent probe for monitoring labile Fe(II) pools in macrophage activations and ferroptosis. Chem. Commun. 58, 2979\u20132982 (2022).","journal-title":"Chem. Commun."},{"key":"398_CR535","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1039\/D2CS00454B","volume":"52","author":"J Yin","year":"2023","unstructured":"Yin, J. et al. Fluorescent probes for ferroptosis bioimaging: advances, challenges, and prospects. Chem. Soc. Rev. 52, 2011\u20132030 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"398_CR536","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.339287","volume":"1191","author":"S Mu","year":"2022","unstructured":"Mu, S. et al. A novel fluorescent probe with large Stokes shift for accurate detection of HOCl in mitochondria and its imaging application. Anal. Chim. Acta 1191, 339287 (2022).","journal-title":"Anal. Chim. Acta"},{"key":"398_CR537","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.120804","volume":"212","author":"Z Li","year":"2020","unstructured":"Li, Z. Imaging of hydrogen peroxide (H(2)O(2)) during the ferroptosis process in living cancer cells with a practical fluorescence probe. Talanta 212, 120804 (2020).","journal-title":"Talanta"},{"key":"398_CR538","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.119264","volume":"248","author":"HC Zhang","year":"2021","unstructured":"Zhang, H. C. et al. Designing an ESIPT-based fluorescent probe for imaging of hydrogen peroxide during the ferroptosis process. Spectrochim. Acta A Mol. Biomol. Spectrosc. 248, 119264 (2021).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"398_CR539","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122684","volume":"234","author":"M Ren","year":"2021","unstructured":"Ren, M. et al. A biotin-guided two-photon fluorescent probe for detection of hydrogen peroxide in cancer cells ferroptosis process. Talanta 234, 122684 (2021).","journal-title":"Talanta"},{"key":"398_CR540","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309907","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. A membrane-targeting aggregation-induced emission probe for monitoring lipid droplet dynamics in ischemia\/reperfusion-induced cardiomyocyte ferroptosis. Adv. Sci. 11, e2309907 (2024).","journal-title":"Adv. Sci."},{"key":"398_CR541","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrclinonc.2015.213","volume":"13","author":"H Gharwan","year":"2016","unstructured":"Gharwan, H. & Groninger, H. Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. Nat. Rev. Clin. Oncol. 13, 209\u2013227 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"398_CR542","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1021\/acs.molpharmaceut.7b01109","volume":"15","author":"YF Song","year":"2018","unstructured":"Song, Y. F. et al. Charge reversible and mitochondria\/nucleus dual target lipid hybrid nanoparticles to enhance antitumor activity of doxorubicin. Mol. Pharm. 15, 1296\u20131308 (2018).","journal-title":"Mol. Pharm."},{"key":"398_CR543","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"398_CR544","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1474-4422(20)30368-9","volume":"20","author":"D Adams","year":"2021","unstructured":"Adams, D. et al. Long-term safety and efficacy of Patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 20, 49\u201359 (2021).","journal-title":"Lancet Neurol."},{"key":"398_CR545","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","volume":"343","author":"MJW Evers","year":"2022","unstructured":"Evers, M. J. W. et al. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. J. Control Release 343, 207\u2013216 (2022).","journal-title":"J. Control Release"},{"key":"398_CR546","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2147\/IJN.S366962","volume":"17","author":"S Scalzo","year":"2022","unstructured":"Scalzo, S. et al. Ionizable lipid nanoparticle-mediated delivery of plasmid DNA in cardiomyocytes. Int. J. Nanomed. 17, 2865\u20132881 (2022).","journal-title":"Int. J. Nanomed."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-024-00398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-024-00398-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-024-00398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T02:16:39Z","timestamp":1740449799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-024-00398-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":546,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1038\/s41413-024-00398-6","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}